Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống
1
/ 82 trang
THÔNG TIN TÀI LIỆU
Thông tin cơ bản
Định dạng
Số trang
82
Dung lượng
12,34 MB
Nội dung
END-BINDING PROTEIN 1 (EB1):
CHARACTERIZATION OF AN EB1 HOMOLOGUE IN
TRYPANOSOMA BRUCEI
LIM LI FERN
(B.Sc.(Hons.), NTU)
A THESIS SUBMITTED
FOR THE DEGREE OF MASTER OF SCIENCE
DEPARTMENT OF BIOLOGICAL SCIENCES
NATIONAL UNIVERSITY OF SINGAPORE
2012
DECLARATION
I hereby declare that the thesis is my original work and it has been written
by me in its entirety. I have duly acknowledged all the sources of
information which have been used in this thesis.
This thesis has also not been submitted for any degree in any university
previously.
____________________________
LIM LI FERN
14 AUGUST 2012
ACKNOWLEDGEMENTS
Nani gigantum humeris insidentes.
The 12th-century Latin quotation attributed to Bernard of Chartres and made famous by
Isaac Newton ("If I have seen further, it is by standing on the shoulders of giants,")
recognizes two things: one, a person's achievements is never merely the sum of the work of
his own hands; two, a person can never be an island who has achieved anything worth
recording.
Both truths have been self-evident to me in my time working on this thesis, and it is only
right that these giants, in every sense of the word, be gratefully given their due recognition
in enabling me to put together this humble report.
Dr. Cynthia He deserves more than just a word of thanks or a grateful mention; she deserves
a medal for her unending patience, remarkable insight, and generous guidance throughout
my years of working under her. No graduate student could claim to have a better supervisor;
her steady direction in the early days of raw unfocused enthusiasm, her infectious
excitement in the (oh so frequent!) periods of experimental doldrums, her unwavering
support through the final days of rushing the last experiments while painfully hammering
out the thesis word by word -this report is a testament to her gift of supervision, and I only
wish that I could have done more to render to her the credit she deserves.
My awesome colleagues, past and present, made the lab a wonderful place to be in even on
the occasional Saturday (and Sunday) evening; there is no way to adequately thank all these
i
fantastic people who have laughed, cried, eaten chocolate after chocolate and argued
pseudo-philosophy with me throughout these years -Dr. Li, Dr. Zhou and Zhang Yu have on
numerous occasions advised me on the finer points of experimental techniques, Sun Ying
mentored me when I first joined the lab as an absolute greenhorn and Wang Min was my
guide in preparing for motherhood as she was in operating the Guava cell counting machine.
Dulani mothered me throughout her stay in the lab, Shima made my day, every day, by
winking her welcome and helping out with my cells when I was away, while Foong Mei and
Shen Qian have made the lab a much cheerier place with their ready smiles and helping
hands. (Shen Qian, keep drawing those awesome pictures!) But it is really this special group
of people -Omar, Ladan and Anaïs -who have been the best friends any person could ask for.
You guys widened my perspectives, challenged my assumptions, went the extra mile then
stuck around for the next two (under the pretext of having to stay late anyway), turned
boring minipreps and IFs into random philosophical battlegrounds and made lunchtimes into
so much more than just shovelling food. If I made it through the course alive and sane, it is
really because you guys were around; thank you, from the bottom of my heart.
I also need to extend a grateful word of thanks to Wang Chao from Dr. Adam Yuan's lab at
the NUS Centre for BioImaging Sciences for his assistance in purifying His-EB1 protein for
antibody generation; his expertise was invaluable, and his kindness in answering my
generally numerous and sometimes inane questions is not soon forgotten.
I would also like to render my appreciation to the National University of Singapore for
providing me with monetary support and the opportunity to experience a season of
exploration and research.
ii
My deepest thanks must now be expressed to my family, who has been a constant source of
every good thing in every possible sense of the word; it will truly have not been possible
without you all. Jauh di mata, dekat di hati, as the Malay saying goes, but thank God for
technology, and thank you for being so understanding all these years when I forgot birthdays
and went AWOL for months; I've been the recipient of so much grace it's bordering on
ridiculous (not that I'm complaining!) and I only hope that this work brings you joy, as it is
but a testament to your unwavering love and care.
Last but far from least, I gratefully thank my husband, Yong Jie, for his constant love and
support throughout the years. We've progressed from being attached to being engaged, and
from being engaged to being married, and from being married to being expectant parents...
all within the time it took to finish this thesis. And what a ride it's been! Thank you for the
journey, and thank you for being around. This humble work is dedicated to you.
Fern
13 August 2012
iii
TABLE OF CONTENTS
ACKNOWLEDGEMENTS
i
TABLE OF CONTENTS
iv
SUMMARY
vi
LIST OF TABLES
1
LIST OF FIGURES
2
LIST OF ABBREVIATIONS
4
CHAPTER 1. Introduction
6
1.1
6
1.2
1.3
An overview of Trypanosoma brucei
1.1.1
T. brucei: Ecological, economic and political impact
6
1.1.2
T. brucei life cycle
6
1.1.3
T. brucei as a model organism
8
1.1.4
Overview on the major ultrastructure features
8
1.1.5
T. brucei cell division
10
An overview of End-binding protein 1 (EB1)
14
1.2.1
EB1 homologues
14
1.2.2
EB1 domain organization
14
1.2.3
EB1 cellular localization
16
1.2.4
EB1 as a keystone +TIP protein
16
1.2.5
Role of EB1 in mitosis
17
1.2.6
Putative mechanisms of EB1 cellular interaction
18
Why study EB1 in T. brucei?
20
CHAPTER 2. Materials and Methods
23
2.1
Molecular cloning
23
2.2
Cell lines, cultivation conditions and plasmid transfection
24
2.3
Clonal selection of stable transformants by limiting dilution
25
2.4
RNAi assay
25
2.5
Anti-TbEB1 antibody
25
2.6
Affinity selection of anti-TbEB1 polyclonal antibody
26
iv
2.7
Immunofluorescence microscopy
27
2.8
Immunoblot analysis
28
CHAPTER 3. Results
3.1
31
T. brucei putative EB1: establishing sequence homology and functional
conservation
31
3.1.1
Bioinformatics
31
3.1.2
Establishing cellular localization of TbEB1
39
3.2
Tracking TbEB1 cellular localization throughout the T. brucei cell cycle
42
3.3
Functional study on TbEB1
44
3.4
Production and characterization of anti-TbEB1 antibody
48
3.4.1
Immunoblot analysis
49
3.4.2
Immunofluorescence assay
50
CHAPTER 4. Discussion
54
4.1
TbEB1: a putative EB1 homologue?
54
4.2
Tracking TbEB1 localization throughout the cell cycle
57
4.3
Characterizing the anti-TbEB1 antibody
58
4.3
Functional study of EB1
62
CHAPTER 5. Conclusion and future direction
63
BIBLIOGRAPHY
66
v
SUMMARY
The African trypanosome Trypanosoma brucei is a protozoan parasite that causes human
African trypanosomiasis in 36 countries spanning sub-Saharan Africa -a major cause of
human mortality as well as a major barrier to sustainable economic growth in these
primarily agrarian societies. T. brucei relies primarily on an extended microtubule-based
cytoskeletal network to define cell shape and regulate its cellular processes, with a
significantly reduced dependency on other traditional elements of the eukaryotic
cytoskeleton. Indeed, actin depletion is non-lethal in procyclic trypanosome cells, and there
is no known trypanosome homologue of intermediate filaments.
Given the parasite's reliance on its microtubule-based network, it was a natural step in the
same direction to search for proteins that regulate microtubule dynamics throughout the
trypanosomal cell cycle. Such a protein was already well-known in many eukaryotes,
spanning organisms as evolutionarily diverse as yeast, sea urchins, plants and humans. This
conservation of function argued for a fundamentally important role for End-Binding Protein
1 (EB1); indeed, EB1 has gathered recognition as a master regulator of microtubule plus-end
dynamics in light of its independent localization and +TIP recruitment to the growing tips of
microtubules. In terms of domain organization, EB1 comprises only two major domains
connected by a flexible, poorly-conserved linker -an amino-terminus Calponin homology
(CH) domain crucial for microtubule-binding, and a carboxyl-terminus EB1-like homology
(EBH) domain which mediates interaction with various +TIPs.
Interestingly, there has been only one study on EB1 conducted thus far on a protozoan
parasite and none at all in a trypanosome system. This study aimed to identify and briefly
vi
characterize a putative EB1 homologue in T. brucei. Sequence alignment of the putative
trypanosome EB1 homologue TbEB1 against established EB1 homologues revealed strong
CH and EBH domain sequence conservation despite poor overall sequence homology. TbEB1
also seemed to retain traditional EB1 localization to microtubule plus-ends; when attached
to a fluorescent tag, this resulted in a distinct fluorescence signal at the posterior tip of the
cell body. To facilitate further study on TbEB1 function and localization, an anti-TbEB1
antibody was raised in rabbit and affinity-purified with His-EB1 protein before use in
subsequent immunofluorescence assays and immunoblot analysis.
Anti-TbEB1 antibody staining revealed two specific TbEB1 localization sites -a signal at the
cell posterior tip that elongated towards the cell anterior as the cell cycle progressed, and a
second localization that closely shadowed the nascent FAZ structure but not the older,
existing FAZ. Both sites appeared to be temporally-regulated and closely associated with cell
cycle progress, resulting in a unique localization pattern.
Attempts were also made to characterize TbEB1 function via EB1-RNAi induction; however,
all attempts at completely depleting TbEB1 has to date been unsuccessful. Partial TbEB1
depletion in a YFP-EB1 over-expression background exerted no adverse effect on cell
morphology nor on cell fitness, as evidenced by the comparative growth curve plotted
against control cells. This may be due TbEB1's ability to function at low cellular levels, but
this observation warrants further investigation, especially since a previous study utilizing
high-throughput screening indicated that TbEB1 RNAi-mediated depletion resulted in a
significant loss of fitness.
vii
LIST OF TABLES
TABLE 1. List of plasmids used in study.
29
Table 2. List of antibodies used in study.
29
TABLE 3. List of constructs and primers used in this study.
30
1
LIST OF FIGURES
FIGURE 1. Cartoon representation of the major cell cycle stages in T. brucei.
13
FIGURE 2. Schematic diagram of human EB1 domain organization.
15
FIGURE 3. Schematic diagram of the major EB1 domains in T. brucei.
31
FIGURE 4. Sequence alignment of full length EB1 homologues from different
species.
33
FIGURE 5a. Sequence alignment of the Calponin Homology (CH) domains.
35
FIGURE 5b. Sequence alignment of the EB-like homology (EBH) domains.
35
FIGURE 6. Sequence alignment of full length putative trypanosomatid EB1
homologues.
37
FIGURE 7a. Sequence alignment of the trypanosomatid putative EB1 Calponin
Homology (CH) domains.
38
FIGURE 7b. Sequence alignment of the trypanosomatid putative EB-like homology
(EBH) domains.
38
FIGURE 8. TbEB1 localized to the posterior tip of the cell.
39
FIGURE 9. Co-staining YFP-EB1 with other cellular markers affirmed TbEB1
localization at microtubule plus ends.
41
FIGURE 10. TbEB1 localization at the posterior end of T. brucei exhibited a temporal
modulation that correlated closely with cell cycle progress.
43
FIGURE 11. Immunoblot analysis of EB1 RNAi up to 5 days post-induction.
45
FIGURE 12. Growth curve of TbEB1-RNAi induced cultures.
45
FIGURE 13. Immunofluorescence analysis of EB1 RNAi induction.
46
FIGURE 14. Anti-TbEB1 immune serum is non-specific in its detection of TbEB1.
49
2
FIGURE 15. Western blot analysis of 29.13 (control) cells and PXS2YFPEB1 cells
using affinity-purified anti-TbEB1.
50
FIGURE 16. Co-staining YTAT cells with anti-TbEB1 and YL1/2 antibody confirmed
a temporally-modulated EB1 localization at the posterior tip of the
cell body.
51
FIGURE 17. Co-staining YTAT cells with anti-TbEB1 and FAZ/flagellum markers
confirmed a temporally-sensitive labelling pattern which closely
traced the nascent FAZ structure.
53
FIGURE 18. Detergent treatment resulted in punctate-like EB1 localization throughout
the cell body.
57
FIGURE 19. Comparative fluorescence labelling of EB1 in a YFP-EB1 over-expressing
cell line confirmed that the anti-TbEB1 antibody labelling pattern was
identical to YFP-EB1 localization.
61
FIGURE 20. Anti-TbEB1 antibody labelling 24 hours post RNAi induction in a YFP-EB1
over-expression background.
61
3
LIST OF ABBREVIATIONS
+TIP
plus-end tracking protein
aa
amino acids
ABS
actin binding site
APC
adenomatous polyposis coli
CAP-Gly
glycine-rich cytoskeleton-associated protein
CH
calponin homology (domain)
DAPI
4, 6-diamidino-2-phenylindole
EB
end-binding protein
EBH
end-binding homology (domain)
FAZ
flagellum attachment zone
HAT
human African trypanosomiasis
IPTG
isopropyl β-D-1-thiogalactopyranoside
LB
Luria broth
MAP
microtubule associated protein
MT
microtubule
MtQ
FAZ microtubule quartet
PCR
polymerase chain reaction
RNAi
RNA interference
4
PVDF
polyvinylidene difluoride
SDS-PAGE
sodium dodecyl sulphate polyacrylamide gel electrophoresis
TBST
Tris-buffered saline - Tween 20 buffer
5
INTRODUCTION
1.1
An overview of Trypanosoma brucei
1.1.1
T. brucei: Ecological, Economic and Political impact
The African trypanosome, Trypanosoma brucei, is the protozoan parasite responsible for the
African sleeping sickness in 36 countries of sub-Saharan Africa, many of which fall in the
category of the poorest developing nations in the world. Many affected populations live
beyond the reach of accessible health services in areas where health systems are either
weakened or non-existent due to political upheaval and rampant poverty -a contributing
factor to the alarming mortality rate of this tropical disease, already fatal in the absence of
treatment. Sleeping sickness, clinically known as human African trypanosomiasis (HAT),
leaves a devastating impact upon the socio-economic profiles of these communities; most
recent conservative estimates place the number of new cases at 30,000 yearly, although
during epidemic periods sleeping sickness surpassed even HIV/AIDS as the greatest cause of
mortality in several villages in the Democratic Republic of Congo, Angola and Southern
Sudan (http://www.who.int/en/). A sub-species, T. brucei brucei, has also been shown to
infect cattle and game animals with the disease 'nagana', curtailing agricultural progress and
thereby reinforcing persisting poverty in afflicted areas (Simarro et al., 2008). There is
currently no vaccine available and the four existing drug treatments are old (Suramin, a
primary treatment for acute human trypanosomiasis, was discovered in 1917 and patented
in 1924), difficult to apply in the field and have toxic side effects (Brun et al., 2010) .
1.1.2
T. brucei life cycle
The trypanosome shuttles between mammalian hosts via a specific arthropod vector, the
tsetse fly (Glossina spp) which is found only in sub-Saharan Africa. A fly is infected when it
6
takes a blood meal on an animal or human harbouring the human-pathogenic parasites. The
parasite then proceeds to establishes itself in the fly midgut, proliferating and transitioning
through several intermediate stages (in strict chronological order) in different locations
before transforming into the infectious metacyclic stage in the salivary glands of the fly
(Roditi and Lehane, 2008; Vickerman et al., 1988).
This process necessitates highly-
coordinated modulation of many basic biological processes (Fenn and Matthews, 2007),
which suggests that trypanosomes are not only capable of adapting to rapidly changing
environments, but that they also possess the capacity for rigorously programmed
differentiation. Once the trypanosomes gain entry into the bloodstream of a new
mammalian host, they proliferate as morphologically slender forms, which later give rise to
stumpy, non-proliferative forms as parasite numbers increase (Matthews et al., 2004). This
not only limits parasite density, thereby prolonging host survival (and therefore increasing
the probability of disease transmission); interestingly, it also results in a uniform cell cycle
arrest of stumpy forms in G1 phase (Shapiro et al., 1984), a process that ensures that reentry into the cell cycle is coordinated with the morphological changes that occur upon
parasite retransmission into the tsetse vector (Matthews and Gull, 1994; Vassella et al.,
1997; Ziegelbauer et al., 1990). This is of particular importance because the successful
completion of the parasite procyclic (or insect-form) cell cycle relies on correct organelle
positioning (Matthews, 2005). Indeed, since trypanosomes morph into at least five
morphologically distinct cell types throughout its transition from vector to host (Sharma et
al., 2009; Van Den Abbeele et al., 1999; Vickerman, 1985) while its microtubule cytoskeleton
remains largely intact throughout the process, accurate spatial and temporal duplication and
segregation of its many single-copy organelles is paramount to the survival of the parasite
(Sherwin and Gull, 1989b).
7
1.1.3
T. brucei as a model organism
The species most used in laboratory studies to date is T. b. brucei -an animal-infectious
species, although it is not pathogenic for humans. Studies thus far have focused on the
procyclic and bloodstream form of the parasite, the two proliferative stages, mainly because
these stages are readily cultured in vitro (Gull, 1999). Several other factors lend themselves
to the recommendation of this ancient eukaryote as an excellent model for addressing
fundamental biological questions of broad interest and applicability, not least the fact that
parasite is genetically tractable -targeted gene knockouts via homologous recombination,
tetracycline-inducible ectopic gene expression of recombinant proteins and interference
RNA (RNAi) as well as systems for forward genetics (Cross, 2001; Kelly et al., 2007; Meissner
et al., 2007; Motyka and Englund, 2004) have since become routine. Reverse genetics and
post-genomic work has also been further expedited by the release of the complete genome
sequence in 2005 (Aslett et al., 2010; Berriman et al., 2005), while production of large scale
RNAi libraries have been efficient and informative launching pads for the study of potentially
interesting genes that have hitherto been overlooked (Alsford et al., 2011; Morris et al.,
2002; Schumann Burkard et al., 2011).
1.1.4
Overview on the major ultrastructure features
The African trypanosoma has a slender, elongated shape measuring about 15µm in length
and 8µm at its widest girth. It possesses a single flagellum that propels the parasite forward,
thus establishing the anterior-posterior axis of the cell. The flagellum, comprising a canonical
9+2 microtubule axoneme and a fibrillar structure known as the paraflagellar rod (PFR), is
laterally attached to the cell body in a left-handed helix, beginning from where it exits the
cell body via the flagella pocket near the posterior end of the cell along to the anterior
8
(Sherwin and Gull, 1989a). This characteristic, polarized shape, which remains intact
throughout much of the cell cycle, is defined by a highly stable, highly cross-linked and
intrinsically polarized sub-pellicular microtubule cytoskeleton (Angelopoulos, 1970). The
microtubules are equally spaced (18-22 nm) and are uniformly arrayed with their plus ends
at the posterior end of the cell (Robinson et al., 1995), with the exception of a microtubule
quartet (MtQ), which is part of a specialized ultrastructure known as the flagellum
attachment zone (FAZ). The FAZ structure, which undergirds and tethers the flagellum along
most of the length of the cell body, is composed of a filament structure which connects the
cell body with the PFR in the flagellum, and the specialized MtQ, which originates close to
the basal bodies and thus possesses a polarity opposite to that of the microtubules in the
sub-pellicular corset (Robinson et al., 1995; Sherwin and Gull, 1989a; Vaughan et al., 2008).
The FAZ thus forms a "seam" in the microtubule corset, and from observation of procyclic
cells in culture, it is believed to define the axis and direction of the cleavage furrow during
cytokinesis (Robinson et al., 1995). The FAZ has also been proposed to control basal body
and flagellar pocket positioning (Absalon et al., 2007; Bonhivers et al., 2008a).
T. brucei also possesses a single copy of many organelles such as the mitochondrion and
Golgi which are precisely positioned within the microtubule corset, resulting in a highly
reproducible and polarized cell. They have been shown to be generally concentrated
between the posterior end and centre of the cell. Many of them also physically tethered
together -the kinetoplast (a mass of catenated DNA which forms the mitochondrial genome)
is physically connected to the proximal end of the two basal bodies (Ogbadoyi et al., 2003;
Robinson and Gull, 1991), while the mature basal body subtends the single flagellum, which
exits the cell via the flagellar pocket (Lacomble et al., 2010). Since the flagellum is tethered
to the cell body via the FAZ, which has also been shown to be in close contact with the
9
flagellar pocket (Lacomble et al., 2009), it is not surprising that correct organelle segregation
during cell division are dependent upon proper FAZ formation and flagellum elongation
(Absalon et al., 2007; Bonhivers et al., 2008b). The single Golgi is also precisely positioned
within the cell, and while there has been no evidence on its physical interaction with other
cytoskeletal structures, it has been shown to share the same spatial-temporal dynamics of
duplication and segregation (Field et al., 2000; He et al., 2004).
1.1.5
T. brucei cell division
T. brucei cell division is a rigorous, spatiotemporally-coordinated and highly reproducible
process -a fact that has significantly aided analysis on the regulation of the cell cycle and
other cellular processes (Robinson and Gull, 1991; Sherwin and Gull, 1989a; Woodward and
Gull, 1990). This has enabled the cell cycle progression to be monitored simply by using a
DNA dye to visualize the nucleus and kinetoplast, the G1 and S phases of which are closely
related to their relative stages of division and segregation; unlike other eukaryotic cells, the
trypanosome coordinates the S-phases of both its DNA masses, namely nuclear DNA, and
the mitochondrial DNA within the kinetoplast (Woodward and Gull, 1990). Cells with one
kinetoplast and one nucleus (1K1N) are in the G1/S phase, while those with two kinetoplasts
and a single nucleus (2K1N) indicate that the cells are in the G2/M phase. Cells bearing
segregated kinetoplasts and nuclei (2K2N) are on the verge of cytokinesis (Sherwin and Gull,
1989a; Woodward and Gull, 1990). In the same manner, antibodies have been raised against
several key parasite organelles and proteins, and immunostaining using these antibodies to
complement DNA staining has opened up even more insight into the coordinated dynamics
of many key cellular processes (Sherwin and Gull, 1989a).
10
The start of the cell cycle begins with the S-phase of mitochondrial DNA, closely followed by
basal body maturation and duplication during the G1-S transition. The maturing pro-basal
body then seeds the new flagellum, which invades the existing flagellar pocket to form the
new flagellar axoneme (Sherwin and Gull, 1989a) (Figure 1B). In the T. brucei procyclic stage,
the new flagellum tip is physically connected to the old flagellum via a mobile
transmembrane junction known as the flagella connector; in a novel example of cytotaxic
inheritance, transmission of cell polarity and axis in cell shape, cell division as well as the
direction of motility of daughter cells takes place as the new flagellum elongates along the
old flagellum, guided by the flagellar connector (Beisson and Sonneborn, 1965; Briggs et al.,
2004; Moreira-Leite et al., 2001). Interestingly, disruption of the new flagellum extension
was shown to result in a shorter FAZ construction, whose length correlates with that of the
new flagellum. Accordingly, the progeny that inherits the new flagellum during cell division is
shorter, thus establishing a direct correlation between the flagellum, FAZ and cell length
(Kohl et al., 2003). Basal body migration is also affected (Absalon et al., 2007; Davidge et al.,
2006); ultimately, disturbance to flagellum growth or flagellum attachment to the cell body
is lethal to the cell (LaCount et al., 2000; Nozaki et al., 1996). Indeed, experiments
generating morphometric measurements have also affirmed that cell length is more closely
related to flagellum length rather than to cell volume (Rotureau et al., 2011). The Golgi
apparatus also duplicates at this time and segregates together with the duplicated
kinetoplasts and flagella, powered by the movement of the segregating basal bodies (Field et
al., 2000; He et al., 2004) (Figure 1C).
This process is followed by nuclear mitosis; nuclear DNA divide within an intact nuclear
membrane which then also segregate (Sherwin and Gull, 1989a) (Figure 1D). The completion
of mitosis leaves one of the two nuclei positioned between the two kinetoplasts, thus
11
ensuring that the ensuing cleavage leaves both daughter cells with a full complement of
organelles (Robinson et al., 1995) (Figure 1E). Interestingly, although mitotic checkpoints in
eukaryotes traditionally track the progress of chromosomal duplication and segregation, the
progress of cytokinesis in T. brucei seems to depend on the completion of kinetoplast
segregation rather than nuclear mitosis; indeed, cytokinesis still occurs during mitotic
spindle disruption, generating zoids -daughter cells with a kinetoplast but no nucleus
(Hammarton et al., 2003; Li and Wang, 2003; Ploubidou et al., 1999). The cleavage furrow
ingresses in a unidirectional manner from the anterior to the posterior of the cell, passing
between the old and the new flagella. Exactly how the site of ingression is determined is still
unknown, although it has been postulated that the FAZ provides the structural information
necessary to position the cleavage furrow. Indeed, the FAZ forms a unique "seam" in the
corset microtubules due to the reverse polarity of the MtQ, and its elongation is
concomitant with the growth of the new flagellum towards the anterior end of the cell
where cleavage initiates (Robinson et al., 1995).
Extension of the new flagellum is accompanied by a concomitant elongation of the subpellicular microtubules at the posterior end and intercalation of new microtubules within
the existing cortical network, resulting in a significant increase in total cell volume (Rotureau
et al., 2011; Sherwin and Gull, 1989b; Sherwin et al., 1987). It has been suggested that the
intercalation of new microtubules indicates that the sub-pellicular microtubules are
distributed semi-conservatively to the daughter cells (Sherwin and Gull, 1989b; Sherwin et
al., 1987), although exactly how this happens at a single microtubule level, or how the cell
coordinates the duplication and segregation of both its microtubules and organelles during
cell division is still unknown. As in mammalian cells, the resulting daughter cells remain
attached for a short period of time after cytokinesis before the final abscission.
12
FIGURE 1. Cartoon representation of the major cell cycle stages in T. brucei.
(A) A single copy of the major organelles (nucleus, kinetoplast, basal body and the golgi apparatus)
are present in an interphase cell. The single flagellum is tethered to the cell body via the FAZ
structure. (B,C,D,E) As the cell undergoes cell division, the organelles duplicate and segregate in strict
chronological and temporal order, which culminates in cytokinesis. This allows parasite cell cycle
stages to also be categorized according to the division and segregation state of the nucleus and
kinetoplast (1K1N, 2K1N, 2K2N), readily visualized with DAPI staining using fluorescence microscopy.
Green minicircles, basal bodies; blue minicircles, kinetoplasts; red dots, Golgi; blue circles, nuclei. The
pink line marks the older, existing flagellum while the yellow one represents the new flagellum. Both
new and old FAZ structures are represented by a series of faint lines undergirding the flagella.
13
1.2
An overview of End-Binding protein 1 (EB1)
1.2.1
EB1 homologues
The EB family comprises a group of microtubule plus-end tracking proteins (+TIPs) which
have been evolutionarily conserved and studied in organisms ranging from yeast to humans.
The first characterized member of the family, human EB1, was identified in a yeast-twohybrid screen for interacting partners of the adenomatous polyposis coli (APC) tumor
suppressor protein COOH terminus; hence the name End-Binding protein (Su et al., 1995).
Since then, EB1 has been found in nearly every organism and cell type studied, even in
unicellular organisms that lack APC, arguing for a more primitive role that predates the
appearance of APC in evolution (Tirnauer and Bierer, 2000). Mammals have three EBs (EB1,
EB2 and EB3) which share 57-66% amino acid identity; although similar in structure, they are
encoded by different genes (Su and Qi, 2001). Single EB homologues have also been
identified in Botryllus schlosseri (EB1-BOTSC) (Pancer et al., 1996), fission yeast
Schizosaccharomyces pombe (Mal3) (Beinhauer et al., 1997) and budding yeast
Saccharomyces cerevisiae (Bim1p) (Schwartz et al., 1997). EB is also conserved in plants Arabidopsis thaliana has been reported to harbour at least 3 EB homologues (Chan et al.,
2003; Mathur et al., 2003).
1.2.2
EB1 domain organization
At a structural level, EB proteins are small, globular dimers which typically contain highly
conserved N- and C-terminal domains that are connected by a less conserved linker
sequence (Figure 2). The N-terminal domain, since determined to be both necessary and
sufficient for microtubule binding, contains a calponin homology (CH) domain, the crystal
structure of which has been shown to be a highly conserved fold (Hayashi and Ikura, 2003;
14
Slep and Vale, 2007). The C-terminal region contains a coiled-coil domain, which mediates
the parallel dimerization of EB protein monomers (Honnappa et al., 2005). The coiled-coil
domain of EB proteins partially overlaps with a unique EB1-like motif known as the endbinding homology (EBH) domain (Honnappa et al., 2005), which is implicated in EB1
interaction with numerous binding partners carrying the SxIP sequence motif (Akhmanova
and Steinmetz, 2008; Honnappa et al., 2009). X-ray crystallography of the EB1 C-terminal
showed that the EBH domain forms a coiled-coil that, in its homodimeric structure, folds
back upon itself to form a 4-helix bundle, with its most invariant and conserved residues
either buried in a deep hydrophobic cavity or forming a polar rim (Honnappa et al., 2005;
Slep et al., 2005). The flexible C-terminal 20-30 residue tail of EB proteins mostly comprises a
low complexity sequence, and is believed to play a role in EB1 self-inhibition. Most EB
proteins, however, also harbour within this region a highly conserved acidic-aromatic EEY/F
sequence motif similar to that found in α-tubulin and CAP-Gly proteins, the latter of which
has been documented to interact with EB1 at this very site (Honnappa et al., 2005;
Komarova et al., 2005; Weisbrich et al., 2007).
FIGURE 2. Schematic diagram of human EB1 domain organization. EB1 comprises two highly
conserved functional modules (the Calponin homology (CH) domain and EB1 homology (EBH) domain)
separated by a more variable linker sequence. The carboxyl-terminus acidic tail is composed of low
complexity sequence. The CH domain and linker sequence (indicated in blue) are positively charged,
while the presence of acidic residues in the EBH domain and disordered tail region (indicated in red)
results in the EB1 C-terminal being negatively charged. Domain boundaries are indicated by residue
positions directly below the diagram.
15
1.2.3
EB1 cellular localization
While many proteins localize to the microtubule cytoskeleton, specific localization to
microtubule plus ends is a characteristic belonging to relatively few. EB1 appears to belong
to this category, exhibiting the propensity to localize with a higher concentration to plus
ends of both cytoskeletal and mitotic microtubules. For example, although over-expressed
GFP-Bim1p in budding yeast was shown to localize to the entire microtubule cytoskeleton,
native levels of GFP-Bim1p expression resulted in a selective localization to microtubule plus
ends and the spindle pole body (Tirnauer et al., 1999). This pattern in also seen in higher
organisms; in mammalian tissue culture cells, EB1 has been shown to localize to the distal
tips of cytoskeletal microtubules, centrosomes, spindle poles as well as the midbody at
different stages of the cell cycle (Morrison et al., 1998). There has been, however,
controversy surrounding the mechanism by which EB1 localizes and attaches to
microtubules; while EB1 has been shown to track growing ends of microtubules
independently of other +TIPs (Bieling et al., 2007) and bind directly to microtubule filaments
(Hayashi and Ikura, 2003), multiple studies have debated whether EB1 first copolymerizes
with tubulin dimers and therefore preferentially accumulates at microtubule plus ends
(Juwana et al., 1999; Slep and Vale, 2007) or whether EB1 specifically recognizes and binds
with increased affinity to microtubule plus ends directly because of its distinct biochemical
and/or structural state (Bieling et al., 2007; Dragestein et al., 2008).
1.2.4
EB1 as a keystone +TIP protein
Despite disagreements on the exact mechanism employed, there is an increasing perception
of EB1 as a master plus-end tracking protein which recruits multiple distinct +TIPs and itself
forms the core for various protein complexes that form at dynamic microtubule plus ends
16
(Lansbergen and Akhmanova, 2006). The budding yeast EB1 homologue Bim1p, for instance,
binds a protein complex containing Kar9 and Myo2p, resulting in the cortical capture of
microtubules which facilitates orientation of the spindle towards the yeast bud site (Korinek
et al., 2000; Lee et al., 2000). Studies have also shown that EB1 activity is crucial for
recruitment of +TIP CLIP-170 to microtubule plus ends in fission yeast (Bieling et al., 2007),
an observation consistent with RNAi studies in mammalian cells, suggesting that EB1 was
pivotal in localizing CLIP-170 to the dynamic ends of microtubules (Komarova et al., 2005). In
vertebrate cells, EB1 is also attributed with the ability to bind APC and target it to the
growing ends of microtubules (Mimori-Kiyosue et al., 2000). The functional significance of
this is still uncertain, although it has been previously shown that ablations of the APC Cterminal EB1 binding domain are frequently associated with familial and sporadic colorectal
cancers (Polakis, 1997).
1.2.5
Role of EB1 in mitosis
EB1's ability to localize independently to plus ends of mitotic and cortical microtubules also
allows it to modulate their dynamic behaviour throughout the cell cycle; shedding light on
EB1's ability interaction with various microtubule structures as well as binding partners
would offer new perspectives on cell cycle progression and cellular processes. For instance,
EB1 has been shown to localize to the interface between kinetochores and growing
microtubules, suggesting that EB1 may modulate microtubule dynamicity during mitosis.
Several experiments seem to support this; deletion of Bim1 results in aberrant spindles and
nuclear migration defects (Schwartz et al., 1997), while loss of Mal3 caused an increase in
the number of cells exhibiting condensed chromosomes and displaced nuclei. While no gross
morphological abnormalities were observed in the spindles of Mal3-deficient cells, overexpression of Mal3, however, resulted in compromised spindle formation, severe growth
17
inhibition and abnormal cell morphology (Beinhauer et al., 1997). Generation of an EB1 null
mutant in Dictyostelium confirms that EB1 is required for proper mitotic spindle formation
(Rehberg and Graf, 2002), an observation that agrees with the RNAi studies carried out in
Drosophila, which also resulted in defective chromosomal segregation (Rogers et al., 2002).
EB1 has also been reported to localize to centrosomes in a process independent of
microtubule association (Louie et al., 2004). Localization of EB1 at the centriole/basal body
of fibroblasts is implicated in the assembly of its primary cilia (Schroder et al., 2007). The
role of EB1 seems to extend beyond its involvement in cilia/flagella assembly; interestingly,
EB1 has also been shown to not only localize to the basal body but also to the flagella tip of
Chlamydomonas reinhardtii, and depletion of EB1 is accompanied by accumulation of
intraflagellar transport (IFT) particles near the flagella tip (Pedersen et al., 2003).
1.2.6
Putative mechanisms of EB1 cellular interaction
Years of study have made it clear that EB1 plays a major role in regulating microtubule
dynamics both in vivo and in vitro systems, although opinions differ as to EB1's precise
influence on the different parameters which govern the dynamic instability of microtubules.
The controversy is exacerbated by differing (and sometimes seemingly conflicting) results
from experiments carried out in different organisms and in various experimental systems.
Bim1p, the budding yeast homologue of EB1, for example, has been shown to promote
microtubule dynamicity (Schwartz et al., 1997; Tirnauer et al., 1999). Indeed, microtubules in
bimI-null cells are considerably less dynamic compared to their wild-type counterparts
(Tirnauer et al., 1999), an observation that agrees with RNAi studies carried out in
Drosophila, which shows that the loss of EB1 causes most of the microtubules to enter a
'paused' state, in which they neither grow nor shrink, although this does not alter overall
microtubule organization in interphase cells (Rogers et al., 2002). This observation mirrors
18
the results obtained from RNAi studies in mouse fibroblast cells, where EB1 depletion
caused microtubules to spend more time pausing and less time in growth (Kita et al., 2006).
Other studies, however, suggest that EB1 stabilizes microtubules through various
mechanisms; readdition of EB1 to EB1-immunodepleted Xenopus egg extracts decreases
microtubule catastrophes and promotes rescues, leading to increased microtubule
polymerization and decreased pausing (Tirnauer et al., 2002). Similar results were reported
for Mal3 in fission yeast (Busch and Brunner, 2004), while in Arabidopsis, over-expression of
AtEB1a-GFP resulted in microtubule stabilization (Chan et al., 2003). EB1 has also been
shown to promote microtubule stabilization in mammalian cell cultures (Wen et al., 2004),
even if it exerts little effect on microtubule growth rates or rescues (Komarova et al., 2009).
Results are equally varied in in vitro studies and experiments in purified systems. One in vitro
study in fission yeast suggested that while Mal3 neither stabilizes nor destabilizes
microtubule tips, it acts to stabilize the microtubule lattice, effectively inhibiting shrinkage
via microtubule depolymerization and increasing the frequency of rescues (Katsuki et al.,
2009). This study seems to affirm previous findings that Mal3 stabilizes the microtubule
lattice seam (Sandblad et al., 2006). Mal3 has also been shown to induce initial formation of
tubulin sheets at growing microtubule ends (Vitre et al., 2008) and then promoting
microtubule assembly into 13-protofilament microtubules with a high proportion of A-lattice
protofilament contact (des Georges et al., 2008), thereby stimulating microtubule
nucleation, sheet growth and closure. Other studies on Mal3 and mammalian EB1, however,
seem to indicate that EB1 actually stimulates microtubule dynamics by increasing the
frequency of both catastrophes and rescues, suggesting instead that in cells EB1 prevents
catastrophes by counteracting other microtubule regulators (Bieling et al., 2007; Komarova
et al., 2009). Still further in vitro experiments described microtubule catastrophe
19
suppression by EB1 (Manna et al., 2008) or asserted that EB1 does not significantly alter
microtubule dynamic instability parameters in the presence of tubulin alone, suggesting that
other cellular factors may modulate EB1 behaviour within the cell (Dixit et al., 2009). Much
of this experimental variation may be due to differences in EB1 concentration used, tubulin
preparations, purification or visualization tags (Zhu, 2011) and other assay conditions, but
the mechanisms employed by EB1 in its role as a regulator of microtubule dynamics still
remain the subject of intense discussion.
1.3
Why study EB1 in T. brucei?
EB1 is known to localize directly to the plus-ends tips of growing microtubules, recruiting
other +TIPs in the process and itself forming the core of fast-changing +TIP complexes
(Akhmanova and Steinmetz, 2008) which dynamically modulate microtubule behaviour.
Coupled with the unidirectional arrangement of microtubules forming the sub-pellicular
corset in which the growing ends point towards the posterior tip of the cell, the
trypanosome microtubule cytoskeleton has been shown to be highly polarized, which in turn
enforces cellular polarity as it directs and coordinates major cellular events such as cell
division. In addition, the FAZ structure (which comprises a microtubular quartet that
collectively possess a polarity opposite to that of the sub-pellicular corset) is also thought to
define the axis and direction of cytokinesis during cell division. As such, it is obvious that
precise modulation and proper regulation of the T. brucei microtubule cytoskeleton is
essential for parasite survival. T. brucei possesses a cytoskeletal organization unlike no
other; its heavy reliance on an extensively developed microtubule cytoskeletal network,
coupled with a reduced dependence on other eukaryotic cytoskeletal elements such as actin
makes it an ideal model in which to study the effects of EB1 and the mechanisms by which
they are exerted on the highly-regulated dynamics of the microtubule network -knowledge
20
crucial for a deeper understanding of parasite behaviour as well as of the mechanisms
underlying EB1 function, form and interaction.
It is interesting to note that although EB1 has been discovered and studied in organisms as
diverse as humans, plants and sea urchins, there has not been a single published attempt to
study EB1 in a trypanosomal system. Indeed, although trypanosomatids rely heavily on a
microtubule-based cytoskeletal system for survival and have been noted to possess a
putative EB1 homologue, there has been to date no published work on the characterization
of trypanosomal EB1 homologues. Remarkably, this also holds true for protozoan parasites
in general, a diverse group of unicellular eukaryotic organisms that have collectively caused
a great number of diseases with devastating economic and socio-political ramifications, of
which T. brucei is a major representative. To date, there has only been one study on EB1 in
protozoan parasites, which was conducted in Giardia lamblia (Kim et al., 2008). T. brucei,
which is fast gaining acceptance as experimentally tractable, attractive model organism due
to the tight spatiotemporal coordination of its cell cycle, the complete sequencing of its
genome, the subsequent rapid development of molecular tools and experimental
techniques, is potentially a good representative model in which to study EB1 -knowledge of
which would be a step forward towards better understanding the molecular workings of
these parasites, and thus possibly pave the way toward better parasitic disease management
and new drug development.
21
In this study, I aim to take the first steps towards verifying and characterizing the putative T.
brucei EB1 homologue; namely, to test and establish sequence and domain homology as well
as to confirm its functional conservation as a +TIP. To this end,
1. I utilized bioinformatics tools to test sequence conservation and domain
preservation,
2. Established EB1 localization within the T. brucei cell,
3. Scrutinized EB1 localization within the context of the T. brucei cell cycle via ectopic
introduction of the YFP-EB1 fusion gene,
4. Attempted to characterize the EB1 RNAi phenotype in order to better understand
EB1 function in the parasite, and
5. Obtained and purified an anti-TbEB1 antibody specifically raised against the putative
T. brucei EB1 homologue, which facilitated further study on EB1 function via
immunofluorescence assays and immunoblot analysis.
22
MATERIALS AND METHODS
2.1
Molecular cloning
The coding sequence of the putative T. brucei EB1 homologue, TbEB1 (gene ID
Tb09.160.1440) was found following a DNA sequence blast search of the T. brucei genome (a
service kindly provided by the TriTryp database at http://tritrypdb.org/tritrypdb/) using the
human EB1 sequence as search input. Desired fragments were then amplified via
polymerase chain reaction (PCR). Annealing temperatures used depended on the size of the
amplified fragment (Table 1), but standard PCR was generally performed in 50µl reactions
using purified T. brucei genome as template, and amplified by either Taq DNA polymerase
(Fermentas) or Advantage2 polymerase (Clontech), depending on the level of desired
accuracy and length of the amplified fragment. All reactions were carried out on DNA
Engine® Peltier Thermal Cycler or My Cycler™ Thermal Cycler (Bio-Rad, USA).
PCR reactions were then subjected to DNA gel electrophoresis (1% agarose gel, run at
10V/cm), after which amplified fragments were identified and excised for purification using
QIAquick PCR Purification Kit (QIAGEN). Purified DNA fragments and their designated
plasmids vectors were subsequently digested with the suitable restriction enzymes,
according to the protocol recommended by the manufacturers of the restriction enzymes
used, before they were incubated together overnight at 16°C at a molar ratio of 1:3
respectively to facilitate ligation of corresponding restriction sites. Ligated constructs were
then transformed into competent E. coli TOP10 cells via heat shock which were
subsequently spread onto LB agar plates containing the necessary antibiotics and incubated
for 12-16 hours at 37°C. This enabled selection of single-clone colonies. Harvested plasmid
23
constructs were then checked for sequence integrity before being reintroduced into E. coli
cells for the purpose of construct amplification.
2.2
Cell lines, cultivation conditions and plasmid transfection
All experiments highlighted in this thesis were conducted in either one of two procyclic cell
lines - the YTat1.1 cell line (Ruben et al., 1983) or the 29.13 cell line (Wirtz et al., 1999). The
YTat1.1 cell line was cultivated at 28°C in Cunningham's medium supplemented with 15%
heat-inactivated fetal bovine serum (Clontech). The 29.13 cell line was maintained at 28°C in
Cunningham medium containing 15% heat-inactivated, tetracycline-free fetal bovine serum
(Clontech) in the presence of 15μg/ml G418 and 50μg/ml hygromycin.
Plasmids could be transfected either transiently or stably into parasite procyclic cells. 3050µg of plasmid was used in a transient transfection, while a stable transfection required at
least 15µg of linearlized plasmid. Approximately 5x107 log-phase cells were mixed with the
required amount of plasmid and subjected to 2 pulses of electroporation (at 1500V) with an
interval of 10 seconds between pulses. All electroporation experiments were carried out on
a BioRad Gene Pulser (1500 V, 25 μF, ∞ Ω) (Biorad). Transiently transfected cells were
checked for ectopic gene expression between 16-28 hours post transfection, while cells
which underwent stable transfection were typically cloned and subjected to antibiotic
selection 6 hours post transfection.
24
2.3
Clonal selection of stable transformants by limiting dilution
In order to obtain clonal cell lines of stably-transfected cells, parasite cultures were serially
diluted in a 96-well microtiter plate such that the parasites were eventually cultured at
dilutions below one cell per well (Rosario, 1981). To accomplish this, parasite cultures
growing in mid log-phase were diluted two fold in each subsequent column of wells,
resulting in a maximum dilution of 211 times the original culture concentration. Plates were
then sealed and incubated at 28°C, 5% CO2 for approximately 2 weeks until clonal cultures
were obtained.
2.4
RNAi assay
A suitable EB1 RNAi sequence was selected using the online program RNAit
(http://trypanofan.path.cam.ac.uk/software/RNAit.html) (Redmond et al., 2003). A 593 bp
length of EB1 coding sequence was introduced into T. brucei in a pZJM vector linearized
with SacII, after which stable transfectants were obtained via cloning by limiting dilution.
Production of double-stranded RNA was induced via addition of 10 µg/ml tetracycline; in
order to ascertain the degree of RNAi penetration, cultures were sampled every 24 hours cells were immunoblotted to check for EB1 protein concentration and examined for YFP-EB1
fluorescence. Cell concentration was also measured every 24 hours (up to 5 days) postinduction.
2.5
Anti-TbEB1 antibody
The His-tagged EB1 (His-EB1) construct was generated by cloning the full-length TbEB1 DNA
sequence in-frame into the E.coli vector pET30a+ vector (Novagen) (Table 3), generating a
25
fusion protein with a N-terminus six histidine residue tag. BL21 E.coli cells were transformed
with the His-EB1 construct and plated on LB agar plates with suitable antibiotics to obtain a
clonal population. Transformed cells were cultured at 37°C to an OD600 of 0.4 before
induction with 0.4 mM isopropyl-beta-D-thiogalactoside (IPTG) overnight at 20°C.
His-EB1 recombinant protein was then affinity-purified using a nickel column (Sigma) and
eluted from the column with several rounds of Equilibrium buffer (0.1 M Tris [pH7.4], 500
mM NaCl and 10% glycerol) supplemented with increasing concentrations of imidazole. The
pooled fractions containing His-EB1 were then exchanged into a gel filtration buffer (25 mM
Tris [pH7.4], 500 mM NaCl) by running the fractions through a Superdex 200 gel filtration
column (GE Healthcare) to prevent protein precipitation by imidazole. Purity of the purified
His-EB1 was assessed using sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE); most His-EB1 protein was recovered in the soluble fraction. Purified protein was
used for polyclonal antibody production in rabbits, and the affinity purified immune serum
of one rabbit was used in all subsequent experiments.
2.6
Affinity purification of anti-TbEB1 polyclonal antibody
A purified fraction of His-EB1 protein was run on an SDS-PAGE, transferred onto a
polyvinylidene difluoride (PVDF) membrane (Biorad). Protein bands were visualized with
Ponceau S dye to facilitate identification and excision of the His-EB1 band. The protein strip
was then blocked with 5% milk in TBS-Tween 20 (TBST) for 20 minutes, followed by two
washes in TBST before incubation with crude antibody serum overnight at 4°C. After three
washes with TBST, bound antibodies were eluted with 0.1 M glycine-HCl buffer (pH2.7)
twice; 5 minutes with gentle mixing for the first fraction, and 3 minutes for the second. 1/10
26
the glycine buffer volume of 2 M Tris (pH8.0) was then used to neutralize the antibody
fractions, which would prevent antibody denaturation as a result of low pH. The resulting
affinity-purified immune serum was then used in all subsequent immunoblotting and
immunofluorescence experiments.
2.7
Immunofluorescence microscopy
Concentrated T. brucei cell suspension was spread on sterile glass coverslips and allowed to
settle. Cells were then permeabilized and fixed in methanol chilled to -20°C for 5-7 minutes.
To better visualize anti-TbEB1 antibody labelling of the parasite cytoskeleton, cells were first
extracted with 1% Nonidet P40 in PBS, then fixed in 4% paraformaldehyde (PFA) for an
additional 20 minutes at 4°C. All coverslips were blocked in 3% BSA for 45 minutes before
antibody labelling to prevent non-specific antibody binding. Fixed cells were then incubated
with primary antibody in blocking solution for an hour at room temperature, then washed
briefly in PBS before incubation with secondary antibody at room temperature for half an
hour. Coverslips with attached cells were then counterstained with 2µg/ml 4, 6-diamidino-2phenylindole (DAPI) for 20 minutes, followed by washing in PBS before a final wash with
Milli-Q water. Coverslips were mounted with Fluorescence Mounting medium
(SouthernBiotech Fluoromount-GTM) and allowed to dry before observation.
All primary antibodies used in this study and their relevant dilutions are listed in Table 3. All
fluorescein-conjugated secondary antibodies (Sigma) were used at 1:2000 dilution. Fixed
cells were observed under a fluorescence microscope (model Axio Observer Z1, Zeiss)
equipped with a CCD camera (model CoolSNAP HQ2, Photometrics). Images were processed
with Adobe Photoshop CS5.
27
2.8
Immunoblot analysis
Parasite cells were washed in PBS and lysed by boiling the samples at 100°C for 5 minutes in
3X Loading Buffer (150 mM Tris-HCl [pH6.8], 6% SDS, 30% glycerol, 2.5% 2-mercaptoethanol,
0.06% Bromophenol Blue). Proteins in cell lysate were resolved by electrophoresis at for 1.5
hours at 120V on a 12% polyacrylamide gel, then electrophoretically transferred onto a
methanol-activated PVDF membrane for an hour at 70V. The membranes were then blocked
with 5% milk in TBST for an hour prior to incubation with their respective primary antibodies
diluted in blocking solution for an hour, after which they were washed briefly in TBST.
Membranes were then incubated with secondary antibodies conjugated with horseradish
peroxidase for half an hour. After a few final washes in TBST, desired protein bands were
visualized with SuperSignal® West Dura Extended Duration Substrate solution (Thermo
Scientific) using a chemiluminescence detector (model ImageQuant LAS 4000, GE
Healthcare).
Should there be a need to reprobe the membrane with different antibodies, the membrane
was stripped with stripping buffer (2% SDS, 62.5 mM Tris-HCl [pH6.8], 100 mM 2mercaptoethanol) for 30 minutes at 60°C, followed by a few brief washes with TBST.
Membranes were then blocked again with 5% milk in TBST before incubation with the
desired primary antibody.
28
Vector
Purpose
Vector origin
pZJM
Constitutive overexpression
Endogenous replacement
via homologous
recombination
RNAi
Modified pCR4Blunt-TOPO
vector
(Morriswood et al., 2009)
(Wang et al., 2000)
pET30a+
Protein expression
Novagen
pXS2
TOPO
(Bangs et al., 1996)
Antibiotic resistance
Cell type
(expression)
Visualization
tag
Linearization
site for stable
transfection
E. coli
T. brucei
Ampicillin
Blasticidin
T. brucei
YFP or BB2
NsiI
Ampicillin
Blasticidin
T. brucei
YFP or BB2
NsiI or PacI
Ampicillin
Phleomycin
-
SacII
Kanamycin
-
T. brucei
E. coli
(strain BL21)
-
-
TABLE 1. List of plasmids used in study.
Antigen
YFP
CC2D
YL1/2
PFR
PAR
L3B2
BB2
α-tubulin
EB1
Host Organism
Rabbit (pAb)
Rabbit (pAb)
Rat (pAb)
Rat (pAb)
Mouse (mAb)
Mouse (mAb)
Mouse (mAb)
Mouse (mAb)
Rabbit (pAb)
Antibody Origin
Abnova
(Zhou et al., 2011)
(Kilmartin et al., 1982)
Abnova
(Ismach et al., 1989)
(Kohl et al., 1999)
(Bastin et al., 1996)
Santacruz biotechnology B512
This study
Staining Pattern
FAZ, basal bodies
Tyrosinolated tubulin
Paraflagellar rod
Paraflagellar rod
FAZ filament
Cytoskeleton
Under investigation
Dilution for IB
1:1000
1:2000
1:100
Dilution for IF
1:500
1:500
1:1000
1:500
1:1000
1:25
1:100
1:1000
1:50
TABLE 2. List of antibodies used in study. Staining patterns for YFP and BB2 are dependent upon the protein to which they are fused. Only anti-YFP, antiTbEB1 and anti-α-tubulin antibodies were used for immunoblot analysis in this study.
29
29
Construct
pXS2YFP-EB1
pXS2BB2-EB1
TOPOYFP-EB1
Insert
Full-length EB1
500 bp of 5' UTR
and
500 bp of 5' end of coding sequence
Primers
Forward: CGGGATCCGACCATCGCAATACCCATGG
Reverse: CGGAATTCTTACTCTGCAGCGTACAATAC
Restriction sites
Forward: BamHI
Reverse: EcoRI
UTR
Forward: CCTTAATTAACGAGGAATGTAATGTTGGGG
Reverse: CCCAAGCTTCGGTAACGATAATAACGGGG
UTR
Forward: PacI
Reverse: HindIII
500 bp 5' coding sequence
Forward: CGGGATCCATGGACCATCGCAATACCC
Reverse: TGCATGCATATATCCCGTCTCACCACTGT
500 bp 5' coding
Forward: BamHI
Reverse: NsiI
pZJM-EB1
RNAi fragment as identified by the
RNAit program
(Redmond et al., 2003)
Forward: GCTCTAGAGGCCTTGGTGATGTGCTTAT
Reverse: GCTCTAGAGTCTGCTTGTCCTCTACGGC
Forward: BamHI
Reverse: EcoRI
pET30a-EB1
Full-length EB1
Forward: GAAGATCTGACCATCGCAATACCCATGG
Reverse: CGGAATTCTTACTCTGCAGCGTACAATAC
Forward: BglII
Reverse: EcoRI
TABLE 3. List of constructs and primers used in this study.
30
30
RESULTS
3.1.
T. brucei putative EB1: establishing sequence homology and functional
conservation
3.1.1
Bioinformatics
A quick blast of the T. brucei genome (available on the TriTryp database) uncovered a single
putative homologue (gene ID: Tb09.160.1440), a predicted coding gene on the T. brucei
chromosome 9. It spans 1611 bases and has a predicted protein molecular weight of
approximately 57 kDa. 2 major domains were identified by the TriTryp blast engine -a Nterminal calponin homology (CH) domain (residues 19-147), and a C-terminal EB1-like
homology (EBH) domain (residues 489-534) with significant E-values (3.5 x 10-20 and 3.2 x
10-14 respectively) (Figure 3).
FIGURE 3. Schematic diagram of the major EB1 domains. EB1 generally comprises 2 major domains
which are linked by a flexible intermediate domain (I). The amino-terminus calponin-homology (CH)
domain is implicated in microtubule-binding, while the carboxyl-terminus EB1-like homology (EBH)
domain (which possesses the propensity to adopt a α-helical coiled coil structure) encompasses the
unique EB1-like sequence motif, and has been shown to be crucial in +TIP interaction. Relative
domain positions in the 57kDa putative T. brucei EB1 homologue, TbEB1, are indicated directly below
the schematic.
However, aligning the T. brucei putative homologue (hereafter referred to as TbEB1) with
sequences of other established EB1 homologues indicated that they shared poor overall
sequence homology, with the alignments returning significantly fewer matches towards the
carboxy terminus (Figure 4). Indeed, human EB1 (268 aa) only shared 8% sequence identity
with TbEB1, while Dictyostelium EB1 (a much longer sequence than human EB1 at 506 aa)
scored a 12% sequence identity. Suspecting that this may be due to (i) the vastly different
31
lengths of different EB1 homologues, (ii) the presence of a poorly-conserved linker sequence
between the two major EB1 domains (Bu and Su, 2003), which prevented alignment
programs from picking up sequence similarities found at the protein C-terminus, and/or (iii)
great evolutionary distances between the homologues (which intuitively suggested an
inherently poor overall sequence homology), conservation of the major protein domains and
motifs were then examined to establish at least a reasonable chance of functional
conservation in TbEB1. Interestingly, alignment of the N-terminal CH domains and Cterminal EBH domains showed decent sequence similarity (NCBI's Blast program's estimate
of sequence identities range from 24% to 38% for CH domains and 25% to 48% for EBH
domains), of which the specific motifs of each domain showed the highest level of
conservation. The N-terminal CH domain, for example, is traditionally defined by a number
of almost invariant core residues, which are likely to be the major residues dictating the
eventual folding of the domain's 3D-structure (Gimona et al., 2002). These residues also
mainly conserved in TbEB1, as are the residues in the actin-binding sites (ABS) which
characterize the CH domain (Figure 5a). Alignment of the C-terminal EBH domains also
indicated decent sequence conservation, particularly at the EB1-like sequence motif which
straddles two α-helices crucial for EBH domain function (Figure 5b) (Honnappa et al., 2005).
It is interesting to note, however, that the slightly less conserved C-terminal EEY/F motif,
shown to be vital for EB1 interaction with several important CAP-Gly +TIPs such as CLIP-170,
is conspicuously absent from the TbEB1 sequence, which terminates prematurely compared
to human EB1 C-terminal sequence.
32
33
FIGURE 4. Sequence alignment of full length EB1 homologues from different species.
Accession numbers are as follows: Homo sapiens (human), SwissProt: Q15691; Xenopus laevis,
GenBank: AAH68630; Drosophila melanogaster, TrEMBL: Q9V9A6; Caenorhabditis elegans, GenBank:
NP_507526; Arabidopsis thaliana, GenBank: BAB11500; Dictyostelium discoideum, TrEMBL: Q8WQ86;
Saccharomyces cerevisiae, SwissProt: P40013; Trypanosoma brucei, TriTrypt gene ID: Tb09.160.1440.
34
FIGURE 5a.. Sequence alignment of the Calponin Homology (CH) domains.
Residues shaded in red (and marked with an asterisk) are invariant, while residues shaded in blue (and
double-dotted) are highly conserved. The red lines indicate actin-binding
actin binding sites (ABS).
FIGURE 5b.. Sequence alignment of the EB-like
EB
homology (EBH) domains.
Residues shaded in red (and marked with an asterisk) are invariant
nt while those in blue (and marked
with a colon)) are highly conserved. The red lines indicate the EB1-like
EB1
sequence
ence motif.
35
Having established that TbEB1 shared decent EB1 domain sequence identity with
established EB1 homologues, the TbEB1 sequence was then blasted on the TriTryp database
to recover potential EB1 homologues in other kinetoplastids. The search turned up serveral
putative homologues from other trypanosomatid species, many of which are agents of
diseases with tremendous socio-political and economic impact. However, no genes with
significant sequence homology with TbEB1 was found in Leishmania, as previously reported
(Berriman et al., 2005). As with the previous alignment attempts between TbEB1 and
established EB1 homologues, aligning the putative trypanosomatid homologues also
resulted in the same trend -the number of matches significantly decreased towards the
carboxy-terminus, resulting in poor overall sequence homology (Figure 6). As before,
aligning only the CH and EBH domains also returned highly-matching alignments (Figures 7a
and 7b), which supports the existence of a very poorly conserved linker sequence . It also
indicates that TbEB1 is, at least at a sequence level, a good representative of trypanosome
EB1 homologues, and could potentially be a good experimental model in which to further
study trypanosome EB1 form and function.
36
FIGURE 6.. Sequence alignment of full length putative trypanosomatid EB1 homologues.
Species identities are as follows: tbru, Trypanosoma brucei; tcon, Trypanosoma congolense;
congolense tviv,
Trypanosoma vivax; tcru, Trypanosoma cruzi strain CL Brener.. Their respective gene IDs are as shown
above. All sequences are declared conserved and hypothetical by the TriTrp database.
37
FIGURE 7a. Sequence alignment of the trypanosomatid putative EB1 Calponin Homology (CH)
domains. Residues shaded in red (and marked with an asterisk) are invariant, while residues shaded
in blue (and double-dotted)
dotted) are highly conserved. The red lines indicate actin-binding
actin binding sites (ABS).
FIGURE 7b.. Sequence alignment of the trypanosomatid putative EB-like
EB like homology (EBH) domains.
Residues shaded in red (and marked with an asterisk) are invariant while those in blue (and marked
with a colon) are highly conserved. The red lines indicate the EB1-like
EB1
sequence
equence motif.
38
3.1.2
Establishing cellular localization of TbEB1
In order to establish TbEB1's localization within the cell, TbEB1 constructs bearing either YFP
or BB2 N-terminal visualization tags were introduced into 29.13 procyclic cells. Upon
observation using fluorescence microscopy, the labelling pattern of over-expressed BB2- or
YFP-tagged EB1 was established to be virtually identical (Figure 8A,C). Cells with a YFP-EB1
construct knock-in at a native locus that replaced the original putative EB1 gene (thus
expressing endogenous levels of YFP-EB1) also appeared to exhibit the same localization
pattern (Figure 8B); however, given the relatively weak YFP signal in these cells, subsequent
localization experiments were conducted using the YFP-EB1 over-expressing cell line.
FIGURE 8. TbEB1 localized to the posterior tip of the cell. TbEB1 exhibited identical localization
patterns regardless of visualization tag (YFP or BB2) or expression level (endogenous or overexpression). Immunofluorescence pictures are arranged above their corresponding DIC picures. (A)
Over-expression YFP-EB1, (B) endogenous-level expression YFP-EB1, (C) over-expression BB2-EB1.
39
Over-expression of YFP-tagged TbEB1 (YFP-EB1) resulted in specific localization to the
posterior tip of the cell, widely accepted to be where the collective plus ends of the
unidirectional corset microtubules converge (Robinson et al., 1995). A weaker signal at the
tapered anterior tip of the cell was also generally observed. Double-labelling of fixed cells
with other cellular markers affirmed the observation; co-staining YFP-EB1-expressing cells
with YL1/2, an antibody which recognizes growing microtubule ends and the basal bodies
(Sherwin et al., 1987), clearly showed TbEB1 localizing as an intense dot at the very tip of
microtubule ends labelled with YL1/2 in interphase cells (Figure 9). The YFP-EB1 fluorescence
pattern was also replicated in cells co-labelled with anti-α-tubulin monoclonal antibody
raised against an epitope which does not undergo post-translational modification (Figure 9).
Interestingly, TbEB1 labelling at the posterior tip of many interphase parasite cells did not
seem to overlap with the ends of the microtubules labelled with either YL1/2 or anti-αtubulin antibody, suggesting that TbEB1 may selectively localize directly to the microtubule
ends rather than processively track the microtubules to the growing ends of the filament.
Co-staining with anti-α-tubulin antibody also showed that YFP-EB1 localization did not
extend into either the existing flagellum or the daughter flagellum (if present), which
remained unlabelled in cells ectopically expressing YFP-EB1 despite the presence of the
microtubular axoneme contained within the flagellum. A low-level general fluorescence was
also observed in the cell body throughout the cell cycle, although fluorescence intensity
varied at different stages of cell division.
40
The results thus far suggest that TbEB1 not only retains decent domain homology when
compared to other established EB1 homologues, but it also localizes to the plus ends of
microtubules in T. brucei, thus suggesting its ability to function as a classical +TIP.
FIGURE 9. Co-staining YFP-EB1 with other cellular markers affirmed TbEB1 localization at
microtubule plus ends. Methanol-fixed interphase cells over-expressing YFP-EB1 co-labelled with (A)
YL1/2 and (B) anti-α-Tubulin (a-Tub) antibodies showed a bright spot at the posterior tip of the cell
body (closed arrows) which generally did not overlap with either YL1/2 or anti-α-Tubulin staining. A
fainter YFP signal was also sometimes observed at the anterior tip of the cell body (open arrows),
believed to be where the FAZ MtQ plus ends are located. YL1/2 labels tyrosinolated tubulin, found at
the growing ends of microtubules and basal bodies (arrowheads).
41
3.2
Tracking TbEB1 cellular localization throughout the T. brucei cell cycle
Interestingly, further immunofluorescence studies of fixed parasite cells suggest that TbEB1
localization is subject to a temporal modulation which strongly correlates with progress
through the T. brucei cell cycle, stages of which are easily identified by taking into
consideration the presence or absence of the daughter flagellum and the length thereof, the
position of the basal bodies, and the position (as well as division state) of the nucleus and
kinetoplast (Figure 10). In cells ectopically expressing YFP-EB1 recombinant protein, TbEB1
localized as an intense dot at the posterior tip of the parasite cell throughout the cell G1 and
S phase, which coincides with the 1K1N stage of cell division. The intense dot then elongated
into a line that stretched towards the anterior from the posterior tip of the cell throughout
the G2/M phase. The line appeared to lengthen in tandem with the nuclear duplication and
segregation the cells progressed from the 2K1N to the 2K2N stage. Interestingly, the line was
generally found on the side of the cell opposing the nascent FAZ structure, although it is still
unclear whether this is an experimental artifact that arose due to flattening a cell and
imaging it on a 2D plane. The specific localization of TbEB1 generally disappeared as the
nucleus completed its mitotic division and the cell progressed into cytokinesis, although the
intensity of general fluorescence in the cell also increased in tandem with cell cycle
progression. Specific TbEB1 localization reappeared at the tip of the new daughter cells after
the completion of cytokinesis.
42
FIGURE 10. TbEB1 localization at the posterior end of T. brucei exhibited a temporal modulation
that correlated closely with cell cycle progress. In 1K1N cells, TbEB1 localized as a specific dot to the
tip of the cell posterior end (closed arrow) (A), and remained there throughout basal body duplication
(B). The segregating basal bodies exert a mechanical force on the physically linked kinetoplast (C),
which then also divides and segregates together with the separating basal bodies (D). Note that the
nascent FAZ structure (visualized here with anti-CC2D antibody) begins to form at this stage as well.
The nucleus then undergoes mitosis and separates, leaving one daughter nucleus in between the
separated kinetoplasts. At this point, TbEB1 localization elongated from a dot into a line that
stretched towards the cell anterior (open arrow points the direction of elongation) (E). Once the
organelles are in place, the cell undergoes cytokinesis (F), and TbEB1 relocalized to the posterior tips
of the new daughter cells.
43
3.3
Functional study on TbEB1
Previous attempts at shedding light on EB1 function in other experimental models and
systems via EB1 knockdown/knockout have resulted in differing outcomes (Komarova et al.,
2009; Tirnauer et al., 1999; Wen et al., 2004). Therefore, in order to study the role of EB1 in
T. brucei, multiple attempts were made to generate a EB1 RNAi cell line. Unfortunately,
several culminating factors (such as the lack of an anti-TbEB1 antibody at this point, the
absence of any obvious phenotype following EB1-RNAi induction and the resulting difficulty
in mass-testing clones for complete RNAi penetration) ultimately made it unfeasible at this
point to generate a RNAi cell line in which TbEB1 was completely depleted. To circumvent
the problem, the EB1-RNAi construct was introduced into a YFP-EB1 over-expression
background. Preliminary results were encouraging; there was substantial decrease in the
fluorescence intensity of YFP-EB1 over the course of 48 hours post RNAi induction,
suggesting that the EB1-RNAi construct was capable of knocking down TbEB1.
Unfortunately, when the experiment was later repeated and allowed to run for a longer
period of time, although cells observed for 5 consecutive days post-induction showed a
further slight decrease in YFP-EB1 intensity after 48 hours, RNAi induction still failed to
completely deplete TbEB1 after 120 hours of RNAi induction (Figure 13). This observation
was supported by a parallel immunoblot experiment; membranes loaded with cell lysate
from induced cells and probed with anti-TbEB1-antibody also registered a decrease in YFPEB1 and endogenous TbEB1 levels (Figure 11). Unfortunately, other than a decrease in the
levels of general fluorescence and, to a lesser extent in the intensity of specific EB1
localization at the posterior tip, no other obvious phenotypes were observed following
partial TbEB1 knockdown; induced EB1-RNAi cells exhibited no gross abnormality in cell
morphology when scrutinized under fluorescence microscopy and the duplication rate of the
induced EB1-RNAi cell line closely paralleled that of the control population (Figure 12).
44
With the present availability of anti-TbEB1 antibody, renewed attempts to obtain a clonal
EB1 RNAi cell line are currently underway.
FIGURE 11. Immunoblot analysis of EB1 RNAi up to 5 days post-induction. EB1 RNAi was induced in a
YFP-EB1 over-expression background. YFP-EB1 levels decreased noticeably after 48 hours, while levels
of endogenous EB1 also decreased gradually over time. However, EB1 RNAi failed to completely
deplete cellular EB1 after 5 days of induction.
FIGURE 12. Growth curve of TbEB1-RNAi induced cultures. Partial depletion of TbEB1 did not appear
to have an adverse effect on T. brucei fitness at 120 hours post-induction, as evidenced by the
minimal difference in doubling index between RNAi-induced and control cultures.
45
FIGURE 13. Immunofluorescence analysis of EB1 RNAi induction.
(A) EB1 RNAi induction in a YFP-EB1 over-expression background
resulted in a significant decrease in YFP intensity after 24 hours,
followed by a further slight decrease until the end of the experiment.
(B) Live-cell imaging of RNAi-induced and control populations 120
hours following RNAi induction confirmed significant, if incomplete,
EB1 depletion in RNAi cells, particularly at the posterior tip of the cell
(indicated with closed arrows). (C) Labelling induced cells with antiTbEB1 antibody revealed a corresponding decrease in endogenous EB1
levels throughout RNAi induction. Closed arrows indicate the posterior
tip of the T. brucei cell body.
46
47
3.4
Production and characterization of anti-TbEB1 antibody
Previous studies in other organisms have raised the possibility that visualization and
purification tags may affect EB1 localization (Landgraf et al., 2012; Zhu, 2011). Moreover, at
higher concentrations EB1 has been shown to bind along the microtubule lattice both in
vitro (Vitre et al., 2008) and in mammalian cells (Ligon et al., 2003) instead of localizing
specifically to the microtubule tips. In order to test the results obtained thus far in the cell
lines over-expressing YFP-EB1 and BB2-EB1, attempts have been made to raise a polyclonal
sera against TbEB1 that could be used in Western blot and immunofluorescence assays. Full
length TbEB1 cDNA was fused to 6xHIS tag and expressed in E. coli. Affinity purified
recombinant protein was then used for rabbit immunization to produce polyclonal
antibodies.
Initial immunofluorescence tests of the immune serum and protein-A purified immune
serum yielded perplexing results. Similar to the localization pattern of YFP-EB1, anti-TbEB1
serum also stained a distinct dot at the posterior tip of the cell. Interestingly, the antibody
also distinctly stained the nucleus/nuclear envelope and localized as a generally punctate
line that seemed to closely follow the FAZ structure (Figure 14A). A corresponding
immunoblot of T. brucei cell lysate probed with anti-TbEB1 antibody resulted in multiple
bands, suggesting that the polyclonal serum may not be altogether specific against TbEB1
(Figure 14B). Immunostaining with protein-A purified immune serum yielded similar results.
48
FIGURE 14. Anti-TbEB1 immune serum is non-specific in its detection of TbEB1. (A) The
fluorescence localization pattern of anti-TbEB1 immune serum from a rabbit immunized
with purified His-EB1 protein showed a strong signal at the posterior tip of the cell body, as
expected (arrow). However, the antibody also picked up a strong signal in the area closely
following the FAZ structure, as well as a slightly weaker signal in the area around the
nucleus. (B) Immunoblot analysis of 29.13 cell lysate probed with anti-TbEB1 immune serum
resulted in multiple bands beside the expected TbEB1 band at ~57kDa.
3.4.1
Immunoblot analysis
The serum was then affinity-purified to harvest anti-TbEB1 antibody fractions which most
specifically recognized purified His-tagged TbEB1. Specificity of the affinity-selected serum
fraction was demonstrated by immunoblotting against endogenous TbEB1 protein and YFPtagged EB1 in both 29.13 cells and YFP-EB1 over-expressing cells. The antibody recognized a
single band at approximately 57 kDa that corresponded to the expected size of endogenous
TbEB1 in 29.13 cells, as well as an additional band at approximately 84 kDa when probed
against total cell lysate of YFP-EB1 over-expressing cells, which corresponded to the
expected size of YFP-tagged EB1 (Figure 15). In contrast, probing total cell lysate of YFP-EB1
49
over-expressing cells with anti-GFP antibody resulted only in a single band at about 84 kDa.
Collectively, these results affirm anti-TbEB1 antibody specificity for TbEB1.
FIGURE 15. Western blot analysis of 29.13 (control) cells and PXS2YFPEB1 cells using
affinity-purified anti-TbEB1. The His-EB1 affinity-purified serum specifically recognized
TbEB1 in both endogenous wild-type and YFP-tagged form. As control, the membrane was
also probed with anti-GFP antibody, which yielded a single band corresponding to YFP-EB1
on the PXS2YFPEB1 lane.
3.4.2
Immunoflorescence assay
Immunofluorescent staining with the purified anti-TbEB1 antibody revealed a pattern that
differed from the staining pattern of the original serum as well as the localization pattern of
over-expressed YFP-EB1. The anti-TbEB1 antibody staining pattern labelled two specific
areas within the trypanosomatid cell with varying levels of intensity: the posterior tip of the
cell and a punctate line which closely followed the nascent daughter FAZ in dividing cells.
Similar to the previous immunofluorescence assays, anti-TbEB1 antibody staining was
localized as a bright dot at the posterior tip of the cell, which elongated concomitant with
nuclear division and segregation (Figure 16).
50
FIGURE 16. Co-staining YTAT cells with anti-TbEB1 and YL1/2 antibody confirmed a temporallymodulated EB1 localization at the posterior tip of the cell body. The staining pattern of anti-TbEB1
antibody confirmed the TbEB1 localization pattern observed in YFP-EB1 over-expressing cells, which
was temporally-regulated and closely correlated to the progress of the cell cycle.
51
Co-staining with anti-L3B2 antibody (FAZ specific) (Kohl et al., 1999) and anti-PAR antibody
(flagellum specific) (Ismach et al., 1989) also revealed a selective staining that closely traced
the newly-forming FAZ, especially in duplicating cells (Figure 17). Similar to the specific
staining at the posterior tip of the cell, immunostaining at this location also exhibited a
temporal modulation throughout the parasite cell cycle -although there was little to no antiTbEB1 antibody staining of the area surrounding the FAZ structure in 1K1N cells, the staining
intensity increased dramatically at the 2K1N stage and was maintained throughout the 2K2N
stage until the parasite cell underwent cytokinesis. Interestingly, there were two prominent
places where the anti-TbEB1 antibody did not label: the area surrounding the older FAZ
structure (Figure 17A) and the flagella, both old and new (Figure 17B). It was also noted that
co-localization of anti-TbEB1 and L3B2 staining at the FAZ area was also not a 100% exact, as
there is generally a diversion in localization pattern near the kinetoplast where the FAZ
begins. The persistent, low level of general fluorescence seen in YFP-EB1 over-expressing
cells was also observed with anti-TbEB1 antibody staining. It is, however, interesting to note
that unlike the even wash of YFP signal in the YFP-EB1 over-expression cell line, the pattern
of antibody staining was often punctate, suggesting that it may reflect a distribution of EB1
to the growing ends of individual microtubules in the sub-pellicular corset.
52
FIGURE 17. Co-staining YTAT cells with anti-TbEB1 and FAZ/flagellum markers confirmed a
temporally-sensitive labelling pattern which closely traced the new growing FAZ structure.
(A) Anti-TbEB1 and L3B2 (FAZ cytoplasmic-filament specific) co-labelling exhibited a colocalization
pattern that shadowed the newly-forming FAZ, beginning from the 2K1N stage (new FAZ labelled with
open arrows). (B) Co-staining with anti-TbEB1 and PAR (flagellum specific) antibodies confirmed that
TbEB1 did not localize to either of the flagella, staining instead a punctate line that closely shadowed
the FAZ undergirding the newer flagellum, indicated with open arrows.
53
DISCUSSION
EB1 has long been studied in various eukaryotes since it was first discovered in 1995, ranging
from single-celled yeast to evolutionarily advanced mammals. In the face of accumulating
evidence, there is increasing acceptance of EB1 as a key regulator of microtubule dynamics
as well as a master integrator of the +TIP network, which has resulted in a concerted and
sustained attempt at understanding the exact role of EB1 in its cellular context.
It is against this backdrop that T. brucei emerges as an attractive organism for the study of
EB1. Its cytoskeleton is primarily dependent on an elaborated tubulin-based network that
forms its major ultrastructures, such as the FAZ component, the sub-pellicular microtubule
corset and its single flagella. In addition, microtubule dynamics are also implicated in the
parasites major cellular events, such as mitosis, organelle segregation and cell division.
Moreover, T. brucei also appears to have a reduced dependence on the other filament
classes generally found in eukaryotic cells; there are presently no known T. brucei
homologues of intermediate filaments, and although homologues for actin-myosin network
components have been identified, the loss of actin in the procyclic form is not lethal at this
stage (Shi et al., 2000).
4.1
TbEB1: a putative EB1 homologue?
Given the parasite's heavy reliance on its microtubule cytoskeleton, it was only natural that
a T. brucei EB1 homologue was hypothesized to exist. Blasting the human EB1 sequence on
the TriTryp database returned a single plausible T. brucei candidate, with an E-value of 3.4 x
10-6, which denotes a significant sequence homology given the difference in sequence length
54
(human EB1, 268aa; TbEB1, 536aa) and evolutionary distance between the two putative
homologues.
The additional presence of a fairly well-conserved N-terminal CH domain and a C-terminal
EBH domain, characteristic of established EB1 homologues, argues that TbEB1 may possess
similar molecular interactions (and thus possibly similar cellular function), which serves to
further strengthen the plausibility of TbEB1 being a true EB1 homologue. However, the
premature truncation of the TbEB1 C-terminal domain in which the EEY/F motif (consistently
found in existing EB1 homologues) appears to be deleted, raises questions as to how TbEB1
then interacts with CAP-Gly proteins which traditionally recognize and bind EB1 at this
particular motif. Interestingly, a T. brucei appears to possess at least one putative CLIP170
homologue (E-value 1.2 x 10-23), a CAP-Gly protein which also localizes to the growing ends
of microtubules; further study into the possibility and nature of TbEB1-CLIP170 interaction
would certainly offer new perspective on microtubule plus-end dynamics in T. brucei. At any
rate, it has been shown that the absence of the EEY/F motif does not compromise TbEB1's
ability to accumulate at microtubule plus ends (Komarova et al., 2005), although it is also
interesting to note that the EEY/F domain has been implicated in EB1 autoinhibition, which
negatively regulates EB1's ability to suppress microtubule shortening (Hayashi et al., 2005;
Manna et al., 2008). It has also been shown in at least two in vitro studies that a
constitutively active mutant exerts a stronger effect on microtubule dynamics even at a very
low EB1:tubulin ratio compared to full length EB1 (Hayashi et al., 2005; Manna et al., 2008),
which suggests that TbEB1 dynamics may differ from standards which have been previously
established for other EB1 homologues.
55
Results from the fluorescence studies also seem to corroborate with existing bioinformatics
data on supporting TbEB1 as a possible EB1 homologue. Following the localization pattern of
established EB1 homologues, YFP- tagged TbEB1 seems to localize to the plus ends of
cortical microtubules which converge at the posterior tip of the trypanosome cell, resulting
in a brightly fluorescent dot which forms at the very tips of the microtubules. This suggests
that TbEB1, like most EB1 homologues, may selectively recognize and associate with growing
microtubule plus ends (either due to its distinct biochemical/structural state) instead of
undergoing processive transport to the microtubule tips (Maurer et al., 2012). It is precisely
this distinct ability to localize independently to the microtubule plus ends that allows EB1 to
act as a key recruiter of modulating +TIPs to the growing tips of microtubules.
Over-expression of YFP-EB1 also resulted in a persistent, low level of fluorescence
throughout the cell body. This supports the findings of a previous study which showed that
new, short microtubules started invading the existing cytoskeletal array from very early on in
the cell cycle by intercalating the old microtubules of the sub-pellicular corset in preparation
of eventual cell division (Sherwin and Gull, 1989b). Localization of EB1 to the plus ends of
individual microtubules, then, would result in the punctate-like distribution of TbEB1
localization, which is clearly and fairly consistently observed in anti-TbEB1 antibody staining.
In addition, another study in budding yeast also showed that over-expressed GFP-Bim1
localized to the entire microtubule skeleton instead of preferentially to the microtubule plus
ends, which may provide an alternative explanation for uniformed fluorescence in the cell
body (Tirnauer et al., 1999). Cellular fluorescence could also be due to the presence of a
cytoplasmic pool of YFP-EB1; interestingly, treating cells with detergent (which strips off
most of the parasite membranes while leaving an intact cytoskeleton) before staining with
anti-TbEB1 antibody resulted in a marked decrease in the intensity of cellular fluorescence,
56
resulting instead in a punctate-like staining of the remaining cytoskeleton (Figure 18). This
observation argues for the presence of free cytoplasmic YFP-EB1, although whether TbEB1
exists in a soluble complex with other proteins or as free molecules remains to be seen;
EB1's ability to bind to free tubulin dimers, for instance, has long been a subject of debate
(Diamantopoulos et al., 1999; Ligon et al., 2006). The combined results seem to suggest that
the low level of cellular fluorescence in cells over-expressing YFP-EB1 might be due to a
combination of several factors discussed above.
FIGURE 18. Detergent treatment resulted in punctate-like EB1 localization throughout the cell body.
Co-labelling fixed YTAT cells extracted with 1% NP40 showed that EB1 localized throughout the subpellicular corset (labelled with anti-α-tubulin antibody) in a punctate-like pattern. The absence of the
typically vivid anti-TbEB1 staining at the posterior tip of the cell body is probably due to the loss of
posterior-end microtubule integrity, resulting in a gaping hole -a feature commonly observed in
detergent-treated cells (indicated by open arrows).
4.2
Tracking TbEB1 localization throughout the cell cycle
TbEB1's temporally-sensitive localization in the dividing trypanosoma cell offers a fresh
perspective on the modulation of microtubule dynamics throughout the cell cycle. Such cell
cycle specificity, an unusual feature among microtubule-associated proteins (MAPs), not
only adds to the unique appeal of studying EB1 as an informative component of microtubule
network regulation but also suggests that EB1 could be used as a new marker for tracking T.
brucei cell cycle progression. It has been postulated that the microtubule corset duplicates in
a semi-conservative manner, with new short microtubules growing in between existing ones
and using them as templates to preserve the shape of the newly-forming sub-pellicular
57
corset (Sherwin and Gull, 1989b). The results obtained in this study seem to agree with this
model of semi-conservative inheritance, not least because the steady fluorescence signal of
YFP-EB1 at the posterior end of the cell (combined with data from co-staining experiments
with YL1/2) suggests that at no time does the existing sub-pellicular corset break down to
reform into two new sets of daughter corsets during cell division. Moreover, the localization
of YFP-EB1 (which elongates from a prominent dot into a line stretching from the posterior
tip of the cell opposite the flagellum) presumably indicates that growing microtubule ends
are concentrated in a strictly-defined area at the posterior end of the parasite cell, which
extends as the cell cycle progresses. Interestingly, the extension of this area as the parasite
moves through the cell cycle (visualized as an elongation of the YFP-EB1 signal) also shows a
strong temporal correlation with nuclear division and segregation, prompting consideration
of the possibility that the two events may also be co-regulated.
4.3
Characterizing the anti-TbEB1 antibody
The discovery of TbEB1's temporally-regulated cellular localization has raised the possibility
that TbEB1 could possibly be used as a new T. brucei cellular marker for the purpose of
tracking the parasite cell cycle progression, or simply for establishing parasite microtubule
cytoskeleton polarity -a potentially useful indicator in assays where cytoskeletal
perturbations are expected. Thus far, only one other trypanosomal protein, known as Gb4,
has been reported to localize to the posterior tip of the parasite. Similar to EB1, this 28kb
protein has been postulated to cap the ends of microtubules and possibly connect them to
the cell membrane (Rindisbacher et al., 1993); however, unlike EB1 Gb4 has not been shown
to exhibit a temporally regulated localization pattern, nor has further work on this protein
been thus far reported. Moreover, EB1 has never been studied in kinetoplastids; given that
TbEB1 shares excellent sequence homology with the putative EB1 homologues in other
58
trypanosomatid species (many of which are direct causes of a wide array of diseases), it is
our hope that an anti-TbEB1 antibody would eventually also be potentially useful in the
study of other trypanosomatids.
The anti-TbEB1 antibody exhibited a complex localization pattern when examined using
immunofluorescence microscopy. While the anti-TbEB1 antibody picked up a similar signal
at the posterior tip of the cell body when compared to the localization pattern of overexpressed YFP-EB1, co-staining experiments with L3B2, a marker that localizes to the
cytoplasmic filament of the FAZ structure (Kohl et al., 1999), also surprisingly showed an
additional prominent signal which closely follows the nascent FAZ in dividing cells. EB1's
unique localization pattern, which presumably traces the plus-ends of growing microtubules,
is reminiscent of the staining pattern of ɣ-tubulin, which instead labels the minus ends of
microtubules. Scott et al., in their 1997 paper, reported that ɣ-tubulin was observed to
localize as a bright dot to the tapered anterior tip of the cell body (where the minus ends of
many of the sub-pellicular microtubules converge), along the cytoplasmic filaments of the
FAZ structure, and as a general, low-level punctate fluorescence throughout the cell body
(Scott et al., 1997). In many ways, this seeming coincidence is not unexpected, since ɣtubulin and EB1 are both microtubule end-tracking proteins (albeit at different ends), and
electron microscopy images of the trypanosome sub-pellicular microtubule array seems to
suggest that the corset is fairly uniform in its distribution of cortical microtubules in spite of
the consistent direction of microtubule polarity (Sherwin and Gull, 1989a). However, unlike
ɣ-tubulin's indiscriminate labelling of both FAZ structures in the cell, TbEB1's selectively
staining on/near the newly-forming FAZ (a pattern which is, as a rule, much weaker or
absent around the older FAZ) is fairly surprising, and indicates a temporally-sensitive facet to
the localization of TbEB1. In a sense, this staining pattern is also reminiscent of the YL1/2
59
antibody staining pattern, which not only stains newly-formed microtubules but also the
nascent daughter flagella in the cell cycle stages preceding kinetoplast segregation (Sherwin
et al., 1987). Like YL1/2, anti-TbEB1 antibody also exhibits a localization that is closely
associated with microtubule growth, subjected to temporal modulation but is at the same
time closely connected to the progress of the parasite cell cycle (Sherwin et al., 1987).
Despite the wealth of information afforded by the initial localization experiments utilizing
constitutive over-expression of YFP-EB1 in T. brucei, it is clear the localization pattern of
over-expressed YFP-EB1 does not entirely match the staining pattern of the anti-TbEB1
antibody. It is still unclear whether the persistent absence of staining along the newlyforming FAZ cytoplasmic filament in YFP-EB1 over-expressing cells is due to the signal being
masked by the increased intensity of background fluorescence, or to the possibility that the
visualization tag may hinder TbEB1 localization to certain parts of the parasite cell.
Interestingly, staining an over-expressing YFP-EB1 cell with anti-TbEB1 antibody resulted in a
staining pattern that was identical with YFP-EB1 localization, suggesting that specific FAZassociated staining could be masked by the increased background fluorescence intensity in
YFP-EB1 over-expressing cells (Figure 19). This possibility is supported by the observation in
cells expressing EB1 RNAi in a YFP-EB1 over-expression background; the FAZ labelling is
sometimes observed 24 hours post-RNAi induction when the cells are probed with antiTbEB1 antibody, although the signal rapidly drops in intensity as the RNAi experiment
progressed (Figure 20). In contrast, no such labelling was seen when YFP fluorescence was
tracked during the same RNAi experiment, supporting the possibility that absence of FAZassociated labelling in YFP-EB1 cells could also be caused by YFP's inability to enter or label
the FAZ structure.
60
FIGURE 19. Comparative fluorescence labelling of EB1 in a YFP-EB1 over-expressing cell line
confirmed that the anti-TbEB1 antibody labelling pattern was virtually identical to YFP-EB1
localization. Both over-expressed YFP-EB1 and anti-TbEB1 staining exhibited the typical, temporallymodulating localization to the posterior tip of the cell (indicated with closed arrows in the 1K1N and
2K2N cells; the direction of signal elongation is indicated in the 2K2N cell by an open arrow). The FAZassociated staining seen in anti-TbEB1 labelling of wild-type YTAT cells was conspicuously absent.
FIGURE 20. Anti-TbEB1 antibody labelling 24 hours post RNAi induction in a YFP-EB1 overexpression background. Partial depletion of YFP-EB1 reduced the YFP signal intensity sufficiently to
allow anti-TbEB1 FAZ-associated staining to be visible (closed arrow).
61
4.4
Functional study of EB1
Although RNAi experiments were attempted in order to characterize the function of the
putative T. brucei EB1 homologue, failure to completely deplete EB1 in T. brucei despite
numerous attempts have unfortunately rendered the results inconclusive. Partial depletion
of EB1 in a YFP-EB1 over-expression background did not appear to exert a drastic negative
impact on cell fitness; a result that seems to contradict a previous high-throughput RNAi
phenotyping report by Alsford et al. which indicated that TbEB1 depletion resulted in
significant loss of fitness in procyclic cells (Alsford et al., 2011). The apparent contradiction
may be due to the possibility that TbEB1's cellular function necessitates only a very small
amount of EB1 to be present. Previous reports on EB1 dynamics offer support to this
possibility; EB1 has been postulated to form the core of the microtubule plus-end complex,
thus requiring only a few EB1 molecules to recruit a complement of other +TIPs which then
exert a cooperative effect on microtubule dynamics (Lansbergen and Akhmanova, 2006).
Moreover, EB1 has also been shown to exhibit rapid turnover at microtubule plus ends,
averaging a dwell-time of 0.81 ± 0.06 seconds and undergoing multiple rounds of
microtubule association/dissociation over the lifetime of a microtubule plus-end structure
(Dixit et al., 2009). Coupled with EB1's ability to bind multiple distinct +TIPs with relatively
weak binding affinities, it has been suggested that +TIPs function in rapidly changing
networks of interaction (Akhmanova and Steinmetz, 2008) -a scenario well suited for a very
low concentration of EB1 to exert a wide area and great variation of effect. Furthermore as
mentioned earlier, the lack of the auto-inhibiting motif EEY/F at the TbEB1 C-terminal may
also possibly endow TbEB1 with a constitutively active phenotype, allowing TbEB1 to exert a
stronger effect even at low EB1:tubulin ratios compared to other EB1 homologues which
possess a C-terminal EEY/F motif.
62
CONCLUSION AND FUTURE DIRECTION
EB1 is a ubiquitous microtubule plus end binding protein that has been conserved across
eukaryotic organisms of remarkably diverse evolutionary progress. EB1 homologues have
since been studied in organisms as varied as yeast, sea urchins, plants and humans,
suggesting a functionally crucial role for EB1 in the regulation of microtubule dynamics.
The highly reproducible spatiotemporal regulation of the T. brucei cell cycle (not only wellunderstood as a result of intense research on this topic but also encountered time and again
in this study) has served to underscore the suitability of the trypanosome as a model
organism for the study of organelle biogenesis, organelle inheritance and microtubule
regulation. Further exploitation of T. brucei's heavy reliance on its microtubule cytoskeletal
network would certainly offer new perspectives on the function and mechanisms of EB1, a
master regulator of +TIP activity and microtubule plus-end dynamics.
The results gathered thus far in this study has been encouraging; not only does the putative
EB1 homologue show significant domain sequence conservation when compared with other
established EB1 homologues, TbEB1 also seems to retain its traditional proclivity for
microtubule plus ends. The implications of this are two-fold; one, the unidirectional
arrangement of microtubules in the sub-pellicular corset translates into a distinct EB1
localization at the posterior tip of the parasite cell body, which automatically positions the
new anti-TbEB1 antibody as a potential cell polarity marker -a great help, for instance, in
experiments that result in disruption of polarity indicators such as the cell shape, organelle
arrangement and flagellum attachment. Second, the temporal modulation of EB1
localization at the posterior end of the cell adds a spatial dimension to the existing
63
knowledge on trypanosome microtubule cytoskeleton inheritance, widely believed to follow
a semi-conservative model. It would be interesting to follow up on this point with 3Dmodelling studies in order to establish a spatially accurate picture of EB1's involvement in
the microtubule dynamics involved in cytoskeleton inheritance.
In addition, TbEB1 also shows a unique, temporally-sensitive localization pattern that closely
shadows the nascent FAZ structure in duplicating cells; a pattern that interestingly does not
extend to the older existing FAZ structure. This unique localization pattern is intriguing, and
warrants further investigation in order to draw more accurate conclusions on EB1's exact
localization and purpose in that locality; immuno-electron microscopy experiments, for
example, would provide invaluable information on the detailed localization of TbEB1.
The present results gleaned from this study have affirmed that further research on the
trypanosomal EB1 homologue would be advantageous to the advancement of knowledge in
both fields of EB1 and T. brucei research. A RNAi-mediated, complete depletion of EB1 in the
trypanosomal cell would provide an invaluable first step towards a more thorough
characterization of EB1 function in T. brucei. Domain truncation studies would then shed
further light on the function of individual domains and help confirm TbEB1 as a true EB1
homologue, as would complementation experiments in BIM1-null yeast and other organisms
with EB1 homologues. Given EB1's widely accepted role as a master regulator of +TIP
activity, it is eventually also of paramount importance to the fuller elucidation of T. brucei
microtubule dynamics to identify, characterize and further study the binding partners of
TbEB1.
64
In the end, however, it is important never to lose sight of the forest for the trees. In the light
of decades of weakened economies and ravaged lives that are the direct result of a rampant
spread of protozoan parasitic diseases like African trypanosomiasis, the need for new
treatment is not only urgent, but also fast becoming necessary. A deeper, more thorough
understanding of the molecular mechanisms underlying parasite survival -such as the role of
EB1 in the regulation of the trypanosome's microtubule dynamics- is key to the control and,
hopefully, eventual eradication of the dreaded disease.
65
BIBLIOGRAPHY
Absalon, S., L. Kohl, C. Branche, T. Blisnick, G. Toutirais, F. Rusconi, J. Cosson, M. Bonhivers,
D. Robinson, and P. Bastin. 2007. Basal body positioning is controlled by flagellum
formation in Trypanosoma brucei. PloS one. 2:e437.
Akhmanova, A., and M.O. Steinmetz. 2008. Tracking the ends: a dynamic protein network
controls the fate of microtubule tips. Nature reviews. Molecular cell biology. 9:309322.
Alsford, S., D.J. Turner, S.O. Obado, A. Sanchez-Flores, L. Glover, M. Berriman, C. HertzFowler, and D. Horn. 2011. High-throughput phenotyping using parallel sequencing
of RNA interference targets in the African trypanosome. Genome research. 21:915924.
Angelopoulos, E. 1970. Pellicular microtubules in the family Trypanosomatidae. The Journal
of protozoology. 17:39-51.
Aslett, M., C. Aurrecoechea, M. Berriman, J. Brestelli, B.P. Brunk, M. Carrington, D.P.
Depledge, S. Fischer, B. Gajria, X. Gao, M.J. Gardner, A. Gingle, G. Grant, O.S. Harb,
M. Heiges, C. Hertz-Fowler, R. Houston, F. Innamorato, J. Iodice, J.C. Kissinger, E.
Kraemer, W. Li, F.J. Logan, J.A. Miller, S. Mitra, P.J. Myler, V. Nayak, C. Pennington, I.
Phan, D.F. Pinney, G. Ramasamy, M.B. Rogers, D.S. Roos, C. Ross, D. Sivam, D.F.
Smith, G. Srinivasamoorthy, C.J. Stoeckert, Jr., S. Subramanian, R. Thibodeau, A.
Tivey, C. Treatman, G. Velarde, and H. Wang. 2010. TriTrypDB: a functional genomic
resource for the Trypanosomatidae. Nucleic acids research. 38:D457-462.
Bangs, J.D., E.M. Brouch, D.M. Ransom, and J.L. Roggy. 1996. A soluble secretory reporter
system in Trypanosoma brucei. Studies on endoplasmic reticulum targeting. The
Journal of biological chemistry. 271:18387-18393.
Bastin, P., Z. Bagherzadeh, K.R. Matthews, and K. Gull. 1996. A novel epitope tag system to
study protein targeting and organelle biogenesis in Trypanosoma brucei. Molecular
and biochemical parasitology. 77:235-239.
Beinhauer, J.D., I.M. Hagan, J.H. Hegemann, and U. Fleig. 1997. Mal3, the fission yeast
homologue of the human APC-interacting protein EB-1 is required for microtubule
integrity and the maintenance of cell form. The Journal of cell biology. 139:717-728.
Beisson, J., and T.M. Sonneborn. 1965. CYTOPLASMIC INHERITANCE OF THE ORGANIZATION
OF THE CELL CORTEX IN PARAMECIUM AURELIA. Proc Natl Acad Sci U S A. 53:275282.
Berriman, M., E. Ghedin, C. Hertz-Fowler, G. Blandin, H. Renauld, D.C. Bartholomeu, N.J.
Lennard, E. Caler, N.E. Hamlin, B. Haas, U. Bohme, L. Hannick, M.A. Aslett, J. Shallom,
L. Marcello, L. Hou, B. Wickstead, U.C. Alsmark, C. Arrowsmith, R.J. Atkin, A.J.
Barron, F. Bringaud, K. Brooks, M. Carrington, I. Cherevach, T.J. Chillingworth, C.
Churcher, L.N. Clark, C.H. Corton, A. Cronin, R.M. Davies, J. Doggett, A. Djikeng, T.
Feldblyum, M.C. Field, A. Fraser, I. Goodhead, Z. Hance, D. Harper, B.R. Harris, H.
Hauser, J. Hostetler, A. Ivens, K. Jagels, D. Johnson, J. Johnson, K. Jones, A.X.
Kerhornou, H. Koo, N. Larke, S. Landfear, C. Larkin, V. Leech, A. Line, A. Lord, A.
Macleod, P.J. Mooney, S. Moule, D.M. Martin, G.W. Morgan, K. Mungall, H.
Norbertczak, D. Ormond, G. Pai, C.S. Peacock, J. Peterson, M.A. Quail, E.
Rabbinowitsch, M.A. Rajandream, C. Reitter, S.L. Salzberg, M. Sanders, S. Schobel, S.
Sharp, M. Simmonds, A.J. Simpson, L. Tallon, C.M. Turner, A. Tait, A.R. Tivey, S. Van
Aken, D. Walker, D. Wanless, S. Wang, B. White, O. White, S. Whitehead, J.
Woodward, J. Wortman, M.D. Adams, T.M. Embley, K. Gull, E. Ullu, J.D. Barry, A.H.
Fairlamb, F. Opperdoes, B.G. Barrell, J.E. Donelson, N. Hall, C.M. Fraser, et al. 2005.
The genome of the African trypanosome Trypanosoma brucei. Science (New York,
N.Y.). 309:416-422.
66
Bieling, P., L. Laan, H. Schek, E.L. Munteanu, L. Sandblad, M. Dogterom, D. Brunner, and T.
Surrey. 2007. Reconstitution of a microtubule plus-end tracking system in vitro.
Nature. 450:1100-1105.
Bonhivers, M., N. Landrein, M. Decossas, and D.R. Robinson. 2008a. A monoclonal antibody
marker for the exclusion-zone filaments of Trypanosoma brucei. Parasites & vectors.
1:21.
Bonhivers, M., S. Nowacki, N. Landrein, and D.R. Robinson. 2008b. Biogenesis of the
trypanosome endo-exocytotic organelle is cytoskeleton mediated. PLoS biology.
6:e105.
Briggs, L.J., P.G. McKean, A. Baines, F. Moreira-Leite, J. Davidge, S. Vaughan, and K. Gull.
2004. The flagella connector of Trypanosoma brucei: an unusual mobile
transmembrane junction. Journal of cell science. 117:1641-1651.
Brun, R., J. Blum, F. Chappuis, and C. Burri. 2010. Human African trypanosomiasis. Lancet.
375:148-159.
Bu, W., and L.K. Su. 2003. Characterization of functional domains of human EB1 family
proteins. The Journal of biological chemistry. 278:49721-49731.
Busch, K.E., and D. Brunner. 2004. The microtubule plus end-tracking proteins mal3p and
tip1p cooperate for cell-end targeting of interphase microtubules. Current biology :
CB. 14:548-559.
Chan, J., G.M. Calder, J.H. Doonan, and C.W. Lloyd. 2003. EB1 reveals mobile microtubule
nucleation sites in Arabidopsis. Nature cell biology. 5:967-971.
Cross, G.A. 2001. African trypanosomes in the 21st century: what is their future in science
and in health? International journal for parasitology. 31:427-433.
Davidge, J.A., E. Chambers, H.A. Dickinson, K. Towers, M.L. Ginger, P.G. McKean, and K. Gull.
2006. Trypanosome IFT mutants provide insight into the motor location for mobility
of the flagella connector and flagellar membrane formation. Journal of cell science.
119:3935-3943.
des Georges, A., M. Katsuki, D.R. Drummond, M. Osei, R.A. Cross, and L.A. Amos. 2008. Mal3,
the Schizosaccharomyces pombe homolog of EB1, changes the microtubule lattice.
Nature structural & molecular biology. 15:1102-1108.
Diamantopoulos, G.S., F. Perez, H.V. Goodson, G. Batelier, R. Melki, T.E. Kreis, and J.E.
Rickard. 1999. Dynamic localization of CLIP-170 to microtubule plus ends is coupled
to microtubule assembly. The Journal of cell biology. 144:99-112.
Dixit, R., B. Barnett, J.E. Lazarus, M. Tokito, Y.E. Goldman, and E.L. Holzbaur. 2009.
Microtubule plus-end tracking by CLIP-170 requires EB1. Proc Natl Acad Sci U S A.
106:492-497.
Dragestein, K.A., W.A. van Cappellen, J. van Haren, G.D. Tsibidis, A. Akhmanova, T.A. Knoch,
F. Grosveld, and N. Galjart. 2008. Dynamic behavior of GFP-CLIP-170 reveals fast
protein turnover on microtubule plus ends. The Journal of cell biology. 180:729-737.
Fenn, K., and K.R. Matthews. 2007. The cell biology of Trypanosoma brucei differentiation.
Current opinion in microbiology. 10:539-546.
Field, H., T. Sherwin, A.C. Smith, K. Gull, and M.C. Field. 2000. Cell-cycle and developmental
regulation of TbRAB31 localisation, a GTP-locked Rab protein from Trypanosoma
brucei. Molecular and biochemical parasitology. 106:21-35.
Gimona, M., K. Djinovic-Carugo, W.J. Kranewitter, and S.J. Winder. 2002. Functional
plasticity of CH domains. FEBS letters. 513:98-106.
Gull, K. 1999. The cytoskeleton of trypanosomatid parasites. Annual review of microbiology.
53:629-655.
Hammarton, T.C., J. Clark, F. Douglas, M. Boshart, and J.C. Mottram. 2003. Stage-specific
differences in cell cycle control in Trypanosoma brucei revealed by RNA interference
of a mitotic cyclin. The Journal of biological chemistry. 278:22877-22886.
67
Hayashi, I., and M. Ikura. 2003. Crystal structure of the amino-terminal microtubule-binding
domain of end-binding protein 1 (EB1). The Journal of biological chemistry.
278:36430-36434.
Hayashi, I., A. Wilde, T.K. Mal, and M. Ikura. 2005. Structural basis for the activation of
microtubule assembly by the EB1 and p150Glued complex. Molecular cell. 19:449460.
He, C.Y., H.H. Ho, J. Malsam, C. Chalouni, C.M. West, E. Ullu, D. Toomre, and G. Warren.
2004. Golgi duplication in Trypanosoma brucei. The Journal of cell biology. 165:313321.
Honnappa, S., S.M. Gouveia, A. Weisbrich, F.F. Damberger, N.S. Bhavesh, H. Jawhari, I.
Grigoriev, F.J. van Rijssel, R.M. Buey, A. Lawera, I. Jelesarov, F.K. Winkler, K.
Wuthrich, A. Akhmanova, and M.O. Steinmetz. 2009. An EB1-binding motif acts as a
microtubule tip localization signal. Cell. 138:366-376.
Honnappa, S., C.M. John, D. Kostrewa, F.K. Winkler, and M.O. Steinmetz. 2005. Structural
insights into the EB1-APC interaction. The EMBO journal. 24:261-269.
Ismach, R., C.M. Cianci, J.P. Caulfield, P.J. Langer, A. Hein, and D. McMahon-Pratt. 1989.
Flagellar membrane and paraxial rod proteins of Leishmania: characterization
employing monoclonal antibodies. The Journal of protozoology. 36:617-624.
Juwana, J.P., P. Henderikx, A. Mischo, A. Wadle, N. Fadle, K. Gerlach, J.W. Arends, H.
Hoogenboom, M. Pfreundschuh, and C. Renner. 1999. EB/RP gene family encodes
tubulin binding proteins. International journal of cancer. Journal international du
cancer. 81:275-284.
Katsuki, M., D.R. Drummond, M. Osei, and R.A. Cross. 2009. Mal3 masks catastrophe events
in Schizosaccharomyces pombe microtubules by inhibiting shrinkage and promoting
rescue. The Journal of biological chemistry. 284:29246-29250.
Kelly, S., J. Reed, S. Kramer, L. Ellis, H. Webb, J. Sunter, J. Salje, N. Marinsek, K. Gull, B.
Wickstead, and M. Carrington. 2007. Functional genomics in Trypanosoma brucei: a
collection of vectors for the expression of tagged proteins from endogenous and
ectopic gene loci. Molecular and biochemical parasitology. 154:103-109.
Kilmartin, J.V., B. Wright, and C. Milstein. 1982. Rat monoclonal antitubulin antibodies
derived by using a new nonsecreting rat cell line. The Journal of cell biology. 93:576582.
Kim, J., S. Sim, K. Song, T.S. Yong, and S.J. Park. 2008. Giardia lamblia EB1 is a functional
homolog of yeast Bim1p that binds to microtubules. Parasitology international.
57:465-471.
Kita, K., T. Wittmann, I.S. Nathke, and C.M. Waterman-Storer. 2006. Adenomatous polyposis
coli on microtubule plus ends in cell extensions can promote microtubule net growth
with or without EB1. Molecular biology of the cell. 17:2331-2345.
Kohl, L., D. Robinson, and P. Bastin. 2003. Novel roles for the flagellum in cell morphogenesis
and cytokinesis of trypanosomes. The EMBO journal. 22:5336-5346.
Kohl, L., T. Sherwin, and K. Gull. 1999. Assembly of the paraflagellar rod and the flagellum
attachment zone complex during the Trypanosoma brucei cell cycle. The Journal of
eukaryotic microbiology. 46:105-109.
Komarova, Y., C.O. De Groot, I. Grigoriev, S.M. Gouveia, E.L. Munteanu, J.M. Schober, S.
Honnappa, R.M. Buey, C.C. Hoogenraad, M. Dogterom, G.G. Borisy, M.O. Steinmetz,
and A. Akhmanova. 2009. Mammalian end binding proteins control persistent
microtubule growth. The Journal of cell biology. 184:691-706.
Komarova, Y., G. Lansbergen, N. Galjart, F. Grosveld, G.G. Borisy, and A. Akhmanova. 2005.
EB1 and EB3 control CLIP dissociation from the ends of growing microtubules.
Molecular biology of the cell. 16:5334-5345.
68
Korinek, W.S., M.J. Copeland, A. Chaudhuri, and J. Chant. 2000. Molecular linkage underlying
microtubule orientation toward cortical sites in yeast. Science (New York, N.Y.).
287:2257-2259.
Lacomble, S., S. Vaughan, C. Gadelha, M.K. Morphew, M.K. Shaw, J.R. McIntosh, and K. Gull.
2009. Three-dimensional cellular architecture of the flagellar pocket and associated
cytoskeleton in trypanosomes revealed by electron microscope tomography. Journal
of cell science. 122:1081-1090.
Lacomble, S., S. Vaughan, C. Gadelha, M.K. Morphew, M.K. Shaw, J.R. McIntosh, and K. Gull.
2010. Basal body movements orchestrate membrane organelle division and cell
morphogenesis in Trypanosoma brucei. Journal of cell science. 123:2884-2891.
LaCount, D.J., S. Bruse, K.L. Hill, and J.E. Donelson. 2000. Double-stranded RNA interference
in Trypanosoma brucei using head-to-head promoters. Molecular and biochemical
parasitology. 111:67-76.
Landgraf, D., B. Okumus, P. Chien, T.A. Baker, and J. Paulsson. 2012. Segregation of
molecules at cell division reveals native protein localization. Nature methods. 9:480482.
Lansbergen, G., and A. Akhmanova. 2006. Microtubule plus end: a hub of cellular activities.
Traffic (Copenhagen, Denmark). 7:499-507.
Lee, L., J.S. Tirnauer, J. Li, S.C. Schuyler, J.Y. Liu, and D. Pellman. 2000. Positioning of the
mitotic spindle by a cortical-microtubule capture mechanism. Science (New York,
N.Y.). 287:2260-2262.
Li, Z., and C.C. Wang. 2003. A PHO80-like cyclin and a B-type cyclin control the cell cycle of
the procyclic form of Trypanosoma brucei. The Journal of biological chemistry.
278:20652-20658.
Ligon, L.A., S.S. Shelly, M. Tokito, and E.L. Holzbaur. 2003. The microtubule plus-end proteins
EB1 and dynactin have differential effects on microtubule polymerization. Molecular
biology of the cell. 14:1405-1417.
Ligon, L.A., S.S. Shelly, M.K. Tokito, and E.L. Holzbaur. 2006. Microtubule binding proteins
CLIP-170, EB1, and p150Glued form distinct plus-end complexes. FEBS letters.
580:1327-1332.
Louie, R.K., S. Bahmanyar, K.A. Siemers, V. Votin, P. Chang, T. Stearns, W.J. Nelson, and A.I.
Barth. 2004. Adenomatous polyposis coli and EB1 localize in close proximity of the
mother centriole and EB1 is a functional component of centrosomes. Journal of cell
science. 117:1117-1128.
Manna, T., S. Honnappa, M.O. Steinmetz, and L. Wilson. 2008. Suppression of microtubule
dynamic instability by the +TIP protein EB1 and its modulation by the CAP-Gly
domain of p150glued. Biochemistry. 47:779-786.
Mathur, J., N. Mathur, B. Kernebeck, B.P. Srinivas, and M. Hulskamp. 2003. A novel
localization pattern for an EB1-like protein links microtubule dynamics to
endomembrane organization. Current biology : CB. 13:1991-1997.
Matthews, K.R. 2005. The developmental cell biology of Trypanosoma brucei. Journal of cell
science. 118:283-290.
Matthews, K.R., J.R. Ellis, and A. Paterou. 2004. Molecular regulation of the life cycle of
African trypanosomes. Trends in parasitology. 20:40-47.
Matthews, K.R., and K. Gull. 1994. Evidence for an interplay between cell cycle progression
and the initiation of differentiation between life cycle forms of African
trypanosomes. The Journal of cell biology. 125:1147-1156.
Maurer, S.P., F.J. Fourniol, G. Bohner, C.A. Moores, and T. Surrey. 2012. EBs recognize a
nucleotide-dependent structural cap at growing microtubule ends. Cell. 149:371382.
69
Meissner, M., C. Agop-Nersesian, and W.J. Sullivan, Jr. 2007. Molecular tools for analysis of
gene function in parasitic microorganisms. Applied microbiology and biotechnology.
75:963-975.
Mimori-Kiyosue, Y., N. Shiina, and S. Tsukita. 2000. The dynamic behavior of the APC-binding
protein EB1 on the distal ends of microtubules. Current biology : CB. 10:865-868.
Moreira-Leite, F.F., T. Sherwin, L. Kohl, and K. Gull. 2001. A trypanosome structure involved
in transmitting cytoplasmic information during cell division. Science (New York, N.Y.).
294:610-612.
Morris, J.C., Z. Wang, M.E. Drew, and P.T. Englund. 2002. Glycolysis modulates trypanosome
glycoprotein expression as revealed by an RNAi library. The EMBO journal. 21:44294438.
Morrison, E.E., B.N. Wardleworth, J.M. Askham, A.F. Markham, and D.M. Meredith. 1998.
EB1, a protein which interacts with the APC tumour suppressor, is associated with
the microtubule cytoskeleton throughout the cell cycle. Oncogene. 17:3471-3477.
Morriswood, B., C.Y. He, M. Sealey-Cardona, J. Yelinek, M. Pypaert, and G. Warren. 2009.
The bilobe structure of Trypanosoma brucei contains a MORN-repeat protein.
Molecular and biochemical parasitology. 167:95-103.
Motyka, S.A., and P.T. Englund. 2004. RNA interference for analysis of gene function in
trypanosomatids. Current opinion in microbiology. 7:362-368.
Nozaki, T., P.A. Haynes, and G.A. Cross. 1996. Characterization of the Trypanosoma brucei
homologue of a Trypanosoma cruzi flagellum-adhesion glycoprotein. Molecular and
biochemical parasitology. 82:245-255.
Ogbadoyi, E.O., D.R. Robinson, and K. Gull. 2003. A high-order trans-membrane structural
linkage is responsible for mitochondrial genome positioning and segregation by
flagellar basal bodies in trypanosomes. Molecular biology of the cell. 14:1769-1779.
Pancer, Z., E.L. Cooper, and W.E. Muller. 1996. A urochordate putative homolog of human
EB1, the protein which binds APC1. Cancer letters. 109:155-160.
Pedersen, L.B., S. Geimer, R.D. Sloboda, and J.L. Rosenbaum. 2003. The Microtubule plus
end-tracking protein EB1 is localized to the flagellar tip and basal bodies in
Chlamydomonas reinhardtii. Current biology : CB. 13:1969-1974.
Ploubidou, A., D.R. Robinson, R.C. Docherty, E.O. Ogbadoyi, and K. Gull. 1999. Evidence for
novel cell cycle checkpoints in trypanosomes: kinetoplast segregation and
cytokinesis in the absence of mitosis. Journal of cell science. 112 ( Pt 24):4641-4650.
Polakis, P. 1997. The adenomatous polyposis coli (APC) tumor suppressor. Biochimica et
biophysica acta. 1332:F127-147.
Redmond, S., J. Vadivelu, and M.C. Field. 2003. RNAit: an automated web-based tool for the
selection of RNAi targets in Trypanosoma brucei. Molecular and biochemical
parasitology. 128:115-118.
Rehberg, M., and R. Graf. 2002. Dictyostelium EB1 is a genuine centrosomal component
required for proper spindle formation. Molecular biology of the cell. 13:2301-2310.
Rindisbacher, L., A. Hemphill, and T. Seebeck. 1993. A repetitive protein from Trypanosoma
brucei which caps the microtubules at the posterior end of the cytoskeleton.
Molecular and biochemical parasitology. 58:83-96.
Robinson, D.R., and K. Gull. 1991. Basal body movements as a mechanism for mitochondrial
genome segregation in the trypanosome cell cycle. Nature. 352:731-733.
Robinson, D.R., T. Sherwin, A. Ploubidou, E.H. Byard, and K. Gull. 1995. Microtubule polarity
and dynamics in the control of organelle positioning, segregation, and cytokinesis in
the trypanosome cell cycle. The Journal of cell biology. 128:1163-1172.
Roditi, I., and M.J. Lehane. 2008. Interactions between trypanosomes and tsetse flies.
Current opinion in microbiology. 11:345-351.
70
Rogers, S.L., G.C. Rogers, D.J. Sharp, and R.D. Vale. 2002. Drosophila EB1 is important for
proper assembly, dynamics, and positioning of the mitotic spindle. The Journal of cell
biology. 158:873-884.
Rosario, V. 1981. Cloning of naturally occurring mixed infections of malaria parasites. Science
(New York, N.Y.). 212:1037-1038.
Rotureau, B., I. Subota, and P. Bastin. 2011. Molecular bases of cytoskeleton plasticity during
the Trypanosoma brucei parasite cycle. Cellular microbiology. 13:705-716.
Ruben, L., C. Egwuagu, and C.L. Patton. 1983. African trypanosomes contain calmodulin
which is distinct from host calmodulin. Biochimica et biophysica acta. 758:104-113.
Sandblad, L., K.E. Busch, P. Tittmann, H. Gross, D. Brunner, and A. Hoenger. 2006. The
Schizosaccharomyces pombe EB1 homolog Mal3p binds and stabilizes the
microtubule lattice seam. Cell. 127:1415-1424.
Schroder, J.M., L. Schneider, S.T. Christensen, and L.B. Pedersen. 2007. EB1 is required for
primary cilia assembly in fibroblasts. Current biology : CB. 17:1134-1139.
Schumann Burkard, G., P. Jutzi, and I. Roditi. 2011. Genome-wide RNAi screens in
bloodstream form trypanosomes identify drug transporters. Molecular and
biochemical parasitology. 175:91-94.
Schwartz, K., K. Richards, and D. Botstein. 1997. BIM1 encodes a microtubule-binding
protein in yeast. Molecular biology of the cell. 8:2677-2691.
Scott, V., T. Sherwin, and K. Gull. 1997. gamma-tubulin in trypanosomes: molecular
characterisation and localisation to multiple and diverse microtubule organising
centres. Journal of cell science. 110 ( Pt 2):157-168.
Shapiro, S.Z., J. Naessens, B. Liesegang, S.K. Moloo, and J. Magondu. 1984. Analysis by flow
cytometry of DNA synthesis during the life cycle of African trypanosomes. Acta
tropica. 41:313-323.
Sharma, R., E. Gluenz, L. Peacock, W. Gibson, K. Gull, and M. Carrington. 2009. The heart of
darkness: growth and form of Trypanosoma brucei in the tsetse fly. Trends in
parasitology. 25:517-524.
Sherwin, T., and K. Gull. 1989a. The cell division cycle of Trypanosoma brucei brucei: timing
of event markers and cytoskeletal modulations. Philosophical transactions of the
Royal Society of London. Series B, Biological sciences. 323:573-588.
Sherwin, T., and K. Gull. 1989b. Visualization of detyrosination along single microtubules
reveals novel mechanisms of assembly during cytoskeletal duplication in
trypanosomes. Cell. 57:211-221.
Sherwin, T., A. Schneider, R. Sasse, T. Seebeck, and K. Gull. 1987. Distinct localization and cell
cycle dependence of COOH terminally tyrosinolated alpha-tubulin in the
microtubules of Trypanosoma brucei brucei. The Journal of cell biology. 104:439446.
Shi, H., A. Djikeng, T. Mark, E. Wirtz, C. Tschudi, and E. Ullu. 2000. Genetic interference in
Trypanosoma brucei by heritable and inducible double-stranded RNA. RNA (New
York, N.Y.). 6:1069-1076.
Simarro, P.P., J. Jannin, and P. Cattand. 2008. Eliminating human African trypanosomiasis:
where do we stand and what comes next? PLoS medicine. 5:e55.
Slep, K.C., S.L. Rogers, S.L. Elliott, H. Ohkura, P.A. Kolodziej, and R.D. Vale. 2005. Structural
determinants for EB1-mediated recruitment of APC and spectraplakins to the
microtubule plus end. The Journal of cell biology. 168:587-598.
Slep, K.C., and R.D. Vale. 2007. Structural basis of microtubule plus end tracking by
XMAP215, CLIP-170, and EB1. Molecular cell. 27:976-991.
Su, L.K., M. Burrell, D.E. Hill, J. Gyuris, R. Brent, R. Wiltshire, J. Trent, B. Vogelstein, and K.W.
Kinzler. 1995. APC binds to the novel protein EB1. Cancer research. 55:2972-2977.
71
Su, L.K., and Y. Qi. 2001. Characterization of human MAPRE genes and their proteins.
Genomics. 71:142-149.
Tirnauer, J.S., and B.E. Bierer. 2000. EB1 proteins regulate microtubule dynamics, cell
polarity, and chromosome stability. The Journal of cell biology. 149:761-766.
Tirnauer, J.S., S. Grego, E.D. Salmon, and T.J. Mitchison. 2002. EB1-microtubule interactions
in Xenopus egg extracts: role of EB1 in microtubule stabilization and mechanisms of
targeting to microtubules. Molecular biology of the cell. 13:3614-3626.
Tirnauer, J.S., E. O'Toole, L. Berrueta, B.E. Bierer, and D. Pellman. 1999. Yeast Bim1p
promotes the G1-specific dynamics of microtubules. The Journal of cell biology.
145:993-1007.
Van Den Abbeele, J., Y. Claes, D. van Bockstaele, D. Le Ray, and M. Coosemans. 1999.
Trypanosoma brucei spp. development in the tsetse fly: characterization of the postmesocyclic stages in the foregut and proboscis. Parasitology. 118 ( Pt 5):469-478.
Vassella, E., B. Reuner, B. Yutzy, and M. Boshart. 1997. Differentiation of African
trypanosomes is controlled by a density sensing mechanism which signals cell cycle
arrest via the cAMP pathway. Journal of cell science. 110 ( Pt 21):2661-2671.
Vaughan, S., L. Kohl, I. Ngai, R.J. Wheeler, and K. Gull. 2008. A repetitive protein essential for
the flagellum attachment zone filament structure and function in Trypanosoma
brucei. Protist. 159:127-136.
Vickerman, K. 1985. Developmental cycles and biology of pathogenic trypanosomes. British
medical bulletin. 41:105-114.
Vickerman, K., L. Tetley, K.A. Hendry, and C.M. Turner. 1988. Biology of African
trypanosomes in the tsetse fly. Biology of the cell / under the auspices of the
European Cell Biology Organization. 64:109-119.
Vitre, B., F.M. Coquelle, C. Heichette, C. Garnier, D. Chretien, and I. Arnal. 2008. EB1
regulates microtubule dynamics and tubulin sheet closure in vitro. Nature cell
biology. 10:415-421.
Wang, Z., J.C. Morris, M.E. Drew, and P.T. Englund. 2000. Inhibition of Trypanosoma brucei
gene expression by RNA interference using an integratable vector with opposing T7
promoters. The Journal of biological chemistry. 275:40174-40179.
Weisbrich, A., S. Honnappa, R. Jaussi, O. Okhrimenko, D. Frey, I. Jelesarov, A. Akhmanova,
and M.O. Steinmetz. 2007. Structure-function relationship of CAP-Gly domains.
Nature structural & molecular biology. 14:959-967.
Wen, Y., C.H. Eng, J. Schmoranzer, N. Cabrera-Poch, E.J. Morris, M. Chen, B.J. Wallar, A.S.
Alberts, and G.G. Gundersen. 2004. EB1 and APC bind to mDia to stabilize
microtubules downstream of Rho and promote cell migration. Nature cell biology.
6:820-830.
Wirtz, E., S. Leal, C. Ochatt, and G.A. Cross. 1999. A tightly regulated inducible expression
system for conditional gene knock-outs and dominant-negative genetics in
Trypanosoma brucei. Molecular and biochemical parasitology. 99:89-101.
Woodward, R., and K. Gull. 1990. Timing of nuclear and kinetoplast DNA replication and
early morphological events in the cell cycle of Trypanosoma brucei. Journal of cell
science. 95 ( Pt 1):49-57.
Zhou, Q., B. Liu, Y. Sun, and C.Y. He. 2011. A coiled-coil- and C2-domain-containing protein is
required for FAZ assembly and cell morphology in Trypanosoma brucei. Journal of
cell science. 124:3848-3858.
Zhu, Z. 2011. Probing Interactions Between Eb1, Microtubules and Actin. In Chemistry and
Biochemistry. Vol. Doctor of Philosophy. University of Notre Dame.
Ziegelbauer, K., M. Quinten, H. Schwarz, T.W. Pearson, and P. Overath. 1990. Synchronous
differentiation of Trypanosoma brucei from bloodstream to procyclic forms in vitro.
European journal of biochemistry / FEBS. 192:373-378.
72
73
[...]... buffer 5 INTRODUCTION 1.1 An overview of Trypanosoma brucei 1.1.1 T brucei: Ecological, Economic and Political impact The African trypanosome, Trypanosoma brucei, is the protozoan parasite responsible for the African sleeping sickness in 36 countries of sub-Saharan Africa, many of which fall in the category of the poorest developing nations in the world Many affected populations live beyond the reach of. .. analysis of EB1 RNAi induction 46 FIGURE 14 Anti-TbEB1 immune serum is non-specific in its detection of TbEB1 49 2 FIGURE 15 Western blot analysis of 29.13 (control) cells and PXS2YFPEB1 cells using affinity-purified anti-TbEB1 50 FIGURE 16 Co-staining YTAT cells with anti-TbEB1 and YL1/2 antibody confirmed a temporally-modulated EB1 localization at the posterior tip of the cell body 51 FIGURE 17 Co-staining... are in the G1/S phase, while those with two kinetoplasts and a single nucleus (2K1N) indicate that the cells are in the G2/M phase Cells bearing segregated kinetoplasts and nuclei (2K2N) are on the verge of cytokinesis (Sherwin and Gull, 1989a; Woodward and Gull, 1990) In the same manner, antibodies have been raised against several key parasite organelles and proteins, and immunostaining using these antibodies... series of faint lines undergirding the flagella 13 1.2 An overview of End-Binding protein 1 (EB1) 1.2.1 EB1 homologues The EB family comprises a group of microtubule plus-end tracking proteins (+TIPs) which have been evolutionarily conserved and studied in organisms ranging from yeast to humans The first characterized member of the family, human EB1, was identified in a yeast-twohybrid screen for interacting... conservation and domain preservation, 2 Established EB1 localization within the T brucei cell, 3 Scrutinized EB1 localization within the context of the T brucei cell cycle via ectopic introduction of the YFP -EB1 fusion gene, 4 Attempted to characterize the EB1 RNAi phenotype in order to better understand EB1 function in the parasite, and 5 Obtained and purified an anti-TbEB1 antibody specifically raised against... YFP -EB1 localization 61 FIGURE 20 Anti-TbEB1 antibody labelling 24 hours post RNAi induction in a YFP -EB1 over-expression background 61 3 LIST OF ABBREVIATIONS +TIP plus-end tracking protein aa amino acids ABS actin binding site APC adenomatous polyposis coli CAP-Gly glycine-rich cytoskeleton-associated protein CH calponin homology (domain) DAPI 4, 6-diamidino-2-phenylindole EB end-binding protein EBH... assay conditions, but the mechanisms employed by EB1 in its role as a regulator of microtubule dynamics still remain the subject of intense discussion 1.3 Why study EB1 in T brucei? EB1 is known to localize directly to the plus-ends tips of growing microtubules, recruiting other +TIPs in the process and itself forming the core of fast-changing +TIP complexes (Akhmanova and Steinmetz, 2008) which dynamically... actin makes it an ideal model in which to study the effects of EB1 and the mechanisms by which they are exerted on the highly-regulated dynamics of the microtubule network -knowledge 20 crucial for a deeper understanding of parasite behaviour as well as of the mechanisms underlying EB1 function, form and interaction It is interesting to note that although EB1 has been discovered and studied in organisms... plus-end tracking protein which recruits multiple distinct +TIPs and itself forms the core for various protein complexes that form at dynamic microtubule plus ends 16 (Lansbergen and Akhmanova, 2006) The budding yeast EB1 homologue Bim1p, for instance, binds a protein complex containing Kar9 and Myo2p, resulting in the cortical capture of microtubules which facilitates orientation of the spindle towards... flagella tip of Chlamydomonas reinhardtii, and depletion of EB1 is accompanied by accumulation of intraflagellar transport (IFT) particles near the flagella tip (Pedersen et al., 2003) 1.2.6 Putative mechanisms of EB1 cellular interaction Years of study have made it clear that EB1 plays a major role in regulating microtubule dynamics both in vivo and in vitro systems, although opinions differ as to EB1' s ... BioImaging Sciences for his assistance in purifying His -EB1 protein for antibody generation; his expertise was invaluable, and his kindness in answering my generally numerous and sometimes inane... An overview of End-binding protein (EB1) 14 1.2.1 EB1 homologues 14 1.2.2 EB1 domain organization 14 1.2.3 EB1 cellular localization 16 1.2.4 EB1 as a keystone +TIP protein 16 1.2.5 Role of EB1. .. labelling of EB1 in a YFP -EB1 over-expressing cell line confirmed that the anti-TbEB1 antibody labelling pattern was identical to YFP -EB1 localization 61 FIGURE 20 Anti-TbEB1 antibody labelling